The problem, the market, the customer in her own words, our product truth, and the offer — one evidence-traced case for a category Livyond can own: acne care that clears without stripping, built for skin over 40.
Every solution picks a side: systemic drugs that medicate the whole body, or harsh topicals that strip fragile skin. The opening is a gentle system that clears without stripping — and the demand, the customer's own words, and the formula all point the same way.
The synthesis of every tab that follows — the one truth Livyond owns, the demand that meets it, and the single reason a jaded, tried-everything woman over 40 chooses this over the pill and the prescription.
Every acne solution on the market picks a side: systemic drugs that medicate the whole body, or harsh topicals built for tough teenage skin. Neither was made for the real situation of a woman over 40 — a hormonal breakout sitting on top of skin that is already dry, thinning, and reactive. That gap is the double-bind, and it is unclaimed.
North Star
The gentle 4-phase system that clears hormonal, cystic breakouts without stripping, burning, or thinning grown-up skin — no spiro, no Accutane, no four-month wait.
A Stage 4–5 jaded market that has tried everything and been served by no one — met by a genuinely differentiated, first-order-profitable product. High, rising search demand in hormonal/cystic terms; a barrier-first product truth; a competitor set that either over-medicates or over-strips.
13,800/mo searches for "cystic acne," 2,992/mo for "hormonal acne" on Amazon. The perimenopause / menopause / adult-acne angle is trending up 12-month. Sophistication Stage 4–5 — burned, skeptical, still shopping for the right vehicle.
A real 4-phase system carrying the studied hormonal-acne actives — niacinamide, glycolic acid, zinc — delivered pH-5.5 and barrier-first, with soursop (~18,000 ORAC) as the calming engine. It clears and calms.
Spiro / Accutane / antibiotics = systemic side effects. Tretinoin / BP / acids = strip a fragile barrier. Nobody speaks to skin that is breaking out and drying out at once. That is the ownable white space.
The only column that wins every row honestly — because it's the only one built for the skin a 47-year-old actually has. And at ~66–78% margins, you can afford to win the auction to reach her.
TAM/SAM/SOM funnel · market-shape radar · sentiment split · direct-response read · loves vs frustrations from the 330-item VOC.
Demand is rising, not fading. The menopause / perimenopause / adult-acne search angle is trending up over the trailing 12 months, on the back of a broader cultural menopause conversation. The category is expanding while it is still uncontested.
And the economics let you take it. At ~$5–6 COGS per unit, the model is first-order-profitable at realistic acquisition costs (66–78% margins). Rising demand + a margin advantage = the window to plant the flag before a competitor does.
From the 330-item VOC sample, approx. Negative dominates: "nothing works" is the single most pervasive emotional thread. Positive clusters almost entirely around a few named wins (spironolactone, tretinoin, heavy moisturizer). Sentiment is measured toward current solutions — the dissatisfaction is the opening.
Awareness: Solution-aware, trending to Product-aware. She knows the category, the mechanism (androgens/sebum, falling estrogen), and the named solutions. She is shopping for the right vehicle.
Sophistication: Stage 4–5 / 5 — jaded, "tried everything," direct claims bounce. Needs a new mechanism + reason-why + heavy validation + risk reversal.
Lead angle: The double-bind — breaking out and drying out. Most ownable, least served.
Message ↔ Market Gaps
The wins. Click any theme to reveal verbatim quotes.
The runaway #1 win — "clear for the first time in decades."
"Spironolactone has been a game changer for me! I was having BAD cystic acne for years… After 1 month: NO more pimples!"
r/Perimenopause★"I started Spironolactone four weeks ago. My skin hasn't been this clear since I was 10 years old… Evidently too much testosterone was always the problem."
r/Perimenopause★"Spironolactone 1000% made my skin look better then it's ever looked, and i had pretty bad hormonal acne aswell! Magic stuff ✨"
r/30PlusSkinCare★"25mg per day is what I've been on for about a year now and it's worked wonders for my skin with zero side effects."
r/30PlusSkinCare★The surprise theme — richer hydration clearing cysts, not causing them.
"The only thing I am doing differently now is using a really heavy night time moisturizer. I use Nivea Creme every night… I swear to god it is clearing up my acne cysts!"
r/SkincareAddiction★"I grabbed some Bio Oil gel for dry skin and after one use it basically erased the cystic acne spots that were brewing… This intense moisturizing method is like a hormonal acne miracle and I haven't seen anyone talking about it."
r/SkincareAddiction★"Now, aged 32, I have been completely acne-free for six months and honestly? I can hardly believe I'm typing this."
r/SkincareAddiction★Redness + acne, without the burn.
"The biggest game changer for me has been azelic acid. It helps the redness, and the acne… the acne is much better. I maybe get one zit here and there now."
r/Perimenopause★"I started cleansing my chin with neutrogena salicylic acid cleanser, then applying Cerave cream also with salicylic acid. No more giant painful zits!"
r/Menopause★"But I swear by niacinimide serum daily."
r/Perimenopause★When estrogen/HRT lands right, skin normalizes.
"we increased my estrogen dose and in a few days my skin was back to normal."
r/Perimenopause★"Been on HRT 6 days now and for the first time in months my acne is calming down a bit."
r/Perimenopause★"Getting my hormones balanced (which included actually taking testosterone) completely eliminated it."
r/Menopause★The pains. Click any theme to reveal verbatim quotes.
Deep, red, week-long, cyclical — the signature zone.
"I get a new lovely, cystic zit probably once a week. They always leave behind a mark that lasts for months. I have a collection of them on my chin."
r/30PlusSkinCare"one or two really big, painful cystic pimples that last at least a week… Nothing works. They are so red and painful."
r/Menopause"I get these blistery pimples on my chin, nose, and occasionally forehead… It's definitely hormonal as it flares up around my period."
r/PerimenopauseThe single most pervasive emotional thread in the whole sample.
"I have suffered from cystic acne for well over 40 years. I was really hoping once I hit menopause it would be done… Nope! It's worse than ever… Absolutely nothing works."
r/Menopause"I've tried literally everything - two rotations on accutane, spiro, antibiotics and other prescriptions, multiple birth controls, gluten-free diet, etc."
r/SkincareAddiction"Revisiting this post after nearly year! Only to say that I still haven't found anything that helps/works."
r/SkincareAddiction"this sh*t is more powerful and determined than any drugs nothing can stop it."
r/PerimenopauseTwo problems that aren't supposed to live on one face.
"It's complicated to treat this topically because peri also brought about Sjogrens and my skin is also super dry."
r/Perimenopause"I have extremely dry, sensitive skin that is highly prone to redness, so I'm reluctant to try anything harsher."
r/Menopause"I wish I had been put on it in my 20's, instead of Accutane followed by decades of burning my face off with harsh actives."
r/Perimenopause"They just push Accutane or throw new creams at me."
"They just push Accutane, which I don't want or throw new creams at me. They're once again having me try some slimy rosacea gel even though this is not rosacea."
r/Menopause"I fought so hard for blood work to see if my hormones were still out of whack… First time ever my bloodwork came back normal… I was so mad."
r/MenopauseThe woman behind the search — her situation, the beliefs that gate her, and the exact pains and desires that copy has to name before it can sell.
Women ~40–55, perimenopausal or menopausal. For roughly two decades she had skin people complimented — she was "the one everyone asked, what do you use?" Then, in her mid-forties, it flipped almost overnight.
She is educated about her own body: she knows it's hormonal, she can name androgens, sebum, falling estrogen. She lives in r/Perimenopause, r/Menopause, r/30PlusSkinCare and r/SkincareAddiction, reading and DIY-experimenting in the dark.
She is time-poor and product-fatigued — "the simpler, the better" — and she has already spent real money on things that failed her. She wants an OTC path that doesn't mean another $200 derm visit.
TRUE — validate: "It's hormonal." "Treatments are too harsh for my aging/sensitive skin." "The doctors won't help; my bloodwork is 'normal.'" These are real — agree, don't argue.
FALSE — the openings: "So topicals are pointless." "I must choose harsh drugs OR live with it." "HRT will fix my skin" (often the cause). These false halves are Livyond's entry points.
60+ verbatim quotes from a 600-item Reddit dataset (~330 usable), themed, plus every major treatment scored by real opinion.
"spironolactone saved my liiiife man. 10/10"
r/30PlusSkinCare★"I'm on 100mg of spironolactone and it's been a miracle. It takes a while to kick in though."
r/Menopause★"The only thing I am doing differently now is using a really heavy night time moisturizer. I use Nivea Creme every night… it is clearing up my acne cysts!"
r/SkincareAddiction★"I grabbed some Bio Oil gel for dry skin and after one use it basically erased the cystic acne spots… like a hormonal acne miracle."
r/SkincareAddiction★"The biggest game changer for me has been azelic acid. It helps the redness, and the acne… I maybe get one zit here and there now."
r/Perimenopause★"we increased my estrogen dose and in a few days my skin was back to normal."
r/Perimenopause★"I am on full HRT. But my skin hasn't improved or changed… my skin is stubborn."
r/Perimenopause"The salicylic acid used to work but like everything else I've tried, it works for a bit but then my skin gets its revenge."
r/Menopause"I have been battling hormonal acne since I was 13. I've tried EVERYTHING… It's affecting my social life and my mental health."
r/30PlusSkinCare"I just want it to stop."
r/30PlusSkinCare"I'm at my wits end with chin breaking out."
r/Menopause"whatever it takes because im ready to tear my sore face off. Its so embarrassing being mid 30s with such severe acne."
r/30PlusSkinCare"This really is like second puberty, but far worse."
r/Perimenopause"I did not agree to a puberty 2.0, especially one that includes stray chin hairs."
r/Perimenopause"I turned 42 and my face went wild like I was a teenager again."
r/Perimenopause"Reverse puberty really is the whole package. Hot flashes, mood swings, and now breakouts like it's 2003 and I just discovered my mom's magnifying mirror."
r/Menopause"It is wild to buy monthly pimple patches again. And to even have to wear tiny stars/happy faces on my face at 47!"
r/Perimenopause"Why didnt our moms warn us?!?!!"
r/Menopause"Dry, thin, sensitive, problematic.. you name it. I also started getting acne and folliculitis out of nowhere and I am so fed up."
r/Perimenopause"Acne wasn't enough for us women now we react to so many things. Any little touch or a hair strand make my face hurt or itchy. It's brutal."
r/Perimenopause"I can't even wear sunscreen without worrying of a flare up. Even shower feels awful as it irritates my skin."
r/Perimenopause"I wish I had been put on it in my 20's, instead of Accutane followed by decades of burning my face off with harsh actives."
r/Perimenopause"I bought cera ve but it burns a little… Do you have a cream u recommend for the dryness?"
r/SkincareAddiction"It's clear but the texture is bad and the skin is so thin."
r/Perimenopause"I get like one or two deep ones every month. So annoying."
r/Perimenopause"It was so bad I would ice my skin sometimes because it would get painfully itchy."
r/Perimenopause"I'd get huge cystic zits there all the time in the same place, like it seemed as if the same pores were blocked badly and getting inflamed."
r/Menopause"My eye recently looked like it went a few rounds in a boxing match with one on the upper part of my nose… Everything swelled up."
r/Menopause"It's too deep for hydrocolloid bandages… A flesh volcano, if you will."
r/SkincareAddiction"I will not stand for the return of this scourge. I have done accutane twice."
r/Perimenopause"i can't look at myself in the mirror without depression and anxiety. I mostly keep lighting dimmed in my house so i don't have to look at my skin so clearly."
r/Perimenopause"My skin was so disgusting a month ago that I couldn't even look in the mirror or I would start crying."
r/Perimenopause"It's embarrassing and destroying my confidence."
r/Perimenopause"I've never had such bad acne in my entire life and it's hard to even get out of bed in the morning knowing what I look like."
r/SkincareAddiction"even when i could manage to cover with makeup and people told me i looked good it was like cool but my FACE HURTS."
r/30PlusSkinCare"So, am i a vain person because i don't want cystic acne at 40? Yep sure am."
r/Menopause"I have reached the point in my life where I cannot try a lot of products are get crazy with my skincare routine. The simpler, the better."
r/Perimenopause"I'm looking for something with no fatty alcohols or acids, no comedogenic oils, no fragrance… no irritants or comedogenics of any kind."
r/SkincareAddiction"has anyone had any success with over the counter products?"
r/Perimenopause"I was hoping to avoid another costly visit to a Dr. Maybe I'll try some of the OTC options first."
r/30PlusSkinCare"sometimes you don't need powerful actives or trendy products to get real results."
r/SkincareAddiction"It's a reasonable and safe thing to try without spending a ton of money or stress."
r/MenopausePro and con, verbatim, with a one-line verdict per treatment. This is the kill-list, sourced.
"Spironolactone. It has been a game changer, and it makes hair grow. You'll have to get a script, and they will likely want to keep an eye on your potassium."
r/Perimenopause★"I should've mentioned I've tried spironolactone as well! It gave me heart palpitations so I had to stop 😞"
r/30PlusSkinCare"spiro seems to be the #1 rec for hormonal acne, but it actually made mine worse."
r/SkincareAddiction"Tretinoin is the big thing lately. I just did a $29 amazon telehealth text appointment to get a Retin-A cream script… delivered by the end of the day!"
r/Perimenopause★"I'm 35f and tretinoin has worked great for me, though I had to struggle for a 3 month long purge before my face cleared up."
r/SkincareAddiction"Adapalene gel fixed mine. It takes a few weeks to start working, so be patient."
r/Menopause"I finally decided to do accutane like my doctor recommended and it changed my life."
r/SkincareAddiction★"Accutane does not heal hormonal acne, even if it clears it could come back."
r/SkincareAddiction"My hormonal acne came back anyway after 2 rounds 🧩"
r/30PlusSkinCare"Yep. I got acne when started patch and again a worsening when I increased dose. My dermatologist said its a side effect of HRT for some."
r/Menopause"Yes. my dermatologist said it's the progesterone. I'm now taking spironolactone to control the acne."
r/Menopause"I definitely attribute the resurgence of my acne to HRT… my painful cystic acne has returned. Personally, I can't tolerate these side effects."
r/Menopause"Birth control pills controlled my peri acne. I think the hormonal fluctuations were the cause and the pill evens all that out."
r/Perimenopause★"I'd rather be sleep deprived than acne riddled."
r/Menopause"currently i'm on month 2 of doxy and it works wonders. my skin hasn't been this clear since pre-bc."
r/SkincareAddiction★"I took doxycycline for a few days and didn't see results. I had to stop taking it because it made me so dizzy."
r/SkincareAddiction"Invest in some really good pimple patches they are Lifesavers."
r/Menopause★"I can't use them. I loved them but realise I can't tolerate the adhesive. It just dries out a massive patch of skin. I'm over it!!!"
r/Perimenopause"I just use a 10% benzoyl peroxide on areas that I'm prone… But I swear by niacinimide serum daily."
r/Perimenopause★"The salicylic acid used to work but like everything else… it works for a bit but then my skin gets its revenge."
r/Menopause"I took DIM on the recommendation from a naturopath… It helped with the horrible cystic acne I had on my jawline/neck."
r/Perimenopause★"Mint tea - spearmint specifically… Drink 1-2 cups a day. It's a reasonable and safe thing to try without spending a ton of money."
r/Menopause"within three months I noticed a major reduction in deep cysts… for the first time in my adult life, I no longer get spots. Not even around my period."
r/SkincareAddiction★"I still find whey protein, like if I try to have a protein shake, will make me break out."
r/PerimenopauseA real, supplier-backed formula — the studied actives mapped to what each one actually does for peri skin, plus the soursop calming engine and bonus gummies.
Resets skin to its natural pH 5.5 acid mantle instead of the stripped alkaline zone. Coconut-derived surfactant + low-dose glycolic acid to lift dead-cell/oil buildup without the squeaky-raw feel. The "don't-strip" jaw.
The hero step, built on niacinamide — oil, pores, the inflamed look, and dark marks in one. Stacked with 3-GA vitamin C, panthenol, allantoin. Essential-oil-free for reactive skin. The acne workhorse.
Dual-weight HA for moisture at two depths + squalane (non-comedogenic plant lipid). The phase every acne routine forgets. The dryness jaw of the double-bind.
Fermented zinc + collagen-supporting peptides + plant stem cells, to firm and support renewal on thinning skin. Use at night / a few times a week if very oily. The nourish-and-firm night step.
Soursop (Annona muricata) — ~18,000 ORAC (≈6× açaí), 200+ compounds — is the calming engine settling the red, reactive, inflamed look across the system. Order includes bonus Cell + Immunity Gummies ×2 (kept even on refund).
The line Livyond stands for, why one-sided fixes fail, and the honest head-to-head that proves the wedge.
The breakout and the dryness are two faces of one hormonal shift hitting one out-of-balance ecosystem. Fixing one side without the other is why every kill-list solution eventually flares. Livyond rebuilds all four pillars.
The wall that keeps moisture in and irritation out. Phase 03 rebuilds it instead of scorching it.
The acid mantle every healthy process depends on. Phase 01 cleanses to it, not below it.
The living surface flora that defends the skin — preserved, not stripped by harsh actives.
Water held at two depths. Dual-weight HA + squalane answer the dryness jaw directly.
| Systemic drugs spiro, Accutane, antibiotics | Harsh topicals tretinoin, BP, acids | Livyond 4-Phase | |
|---|---|---|---|
| Side effects | ✗ Palpitations, dizziness, gut worry | ✗ Burning, peeling, "purge" | ✓ Topical, no systemic effects — patch-test citrus oils |
| Gentle on a fragile barrier | ⚠ N/A — taken internally | ✗ Strips and thins the barrier | ✓ pH-5.5, barrier-first; Phase 03 rebuilds hydration |
| Works on hormonal chin/jaw breakouts | ⚠ Sometimes — slow, inconsistent | ⚠ Fights breakout, aggravates dryness | ✓ Niacinamide + glycolic + zinc, gently delivered |
| Fades post-acne marks | ✗ Not its job | ⚠ Eventually, with irritation | ✓ Niacinamide + 3-GA vitamin C |
| Prescription needed | ✗ Yes — and a willing doctor | ✗ Often (tret) | ✓ No prescription, no office |
| Time to see something | ~3–4 months | Weeks — after the purge | ✓ Many notice calmer redness in first weeks |
Soursop = ownable. The heritage, calming, distinctive hook that sidesteps Stage-5 ad fatigue. It's the story no competitor can copy — the new mechanism that gives a jaded reader permission to believe again.
Niacinamide = efficacy. The most-researched active for hormonal acne carries the actual clearing claim. Soursop earns attention; niacinamide + glycolic + zinc earn results. Lead with the ownable, back with the efficacy.
The angle is locked; these are the headlines, hooks, and one-liners built on it — pulled from the customer's own language, ready to test. Lead with the pain, prove with the mechanism, close on the risk-reversal.
"You're breaking out and drying out — a system built for skin that's doing both, without spiro, Accutane, or burning your face off." Run the kill-list, resolve into "get the woman in the mirror back," close offer-led. Audience is Stage 4–5 jaded: identify first, sell second.
For: everyone in the niche. Hook: breaking out AND drying out — nothing's built for both.
For: the "this isn't me anymore" reader. Hook: "puberty 2.0 — but I can't use teenager products."
For: the spiro / Accutane-wary. Hook: clear it without a pill running through your whole body.
For: the post-acne-marks reader. Hook: fade the marks, stop flinching at the mirror.
Sub: The gentle 4-phase system — built around soursop and the clinical actives that actually work on hormonal acne (niacinamide, glycolic, zinc). No spiro. No Accutane. No "wait 4 months and pray."
Sub: If acne treatments burn your aging skin and the "gentle" stuff breaks you out, here's the system built for exactly that.
"Why is a 48-year-old breaking out like a teenager — and what actually stops it?"
"The reason your acne products stopped working after 40 — it's not your routine."
"Perimenopause doesn't just bring hot flashes. Nobody warned us about this one."
"Breaking out AND dry at the same time? There's a name for it — and a fix."
Alts: "For skin that's breaking out and drying out." · "Strong for the breakout, gentle for grown-up skin." · "The acne system built for skin over 40."
Age 42–48. Clear, complimented skin for 20 years — then near-overnight cystic breakouts on the chin/jaw. Confused, not yet jaded.
Awareness: problem → solution-aware · Mindset: shock & grief — "what did I do wrong?"
In her words: "I did not agree to a puberty 2.0." · "breaking out worse than I did in high school."
Core fear: is this permanent? is this the new me?
Tried: her old products (that stopped working), drugstore acne washes.
Angle: identity — "your skin changed the rules."
Sub: You didn't do anything wrong — perimenopause rewrote your skin. Here's the system built for the skin you have now.
Lead with: the WHY (education) + founder "this happened to me too."
Flip: reassure — it's hormonal and normal, not your fault.
CTA: "See why it's happening →"
Age 45–55. Years of hormonal acne. Has run the gauntlet — spiro, tretinoin, Accutane, antibiotics, derms, birth control. Ingredient-literate and skeptical.
Awareness: product-aware · Sophistication: Stage 5 (jaded) · Mindset: "prove it, I've wasted enough money."
In her words: "tried everything, nothing works." · "spiro gave me palpitations." · "Accutane came back."
Core fear: another overpriced thing that does nothing; systemic side effects.
Tried: the entire kill-list.
Angle: kill-list + new mechanism + anti-prescription + proof.
Sub: No spiro, no Accutane, no four-month wait — the studied actives (niacinamide, glycolic, zinc) delivered gently. Tried everything? You've only tried one of two buckets.
Lead with: the comparison table + ingredient studies + reorder proof.
Flip: "not another teenager's product" · 60-day money-back, keep the gummies.
CTA: "See the honest comparison →"
Age 44–55. Sensitive / rosacea-prone, dry and reactive — the double-bind at its worst: acne and a barrier that can't take actives.
Awareness: solution-aware · Mindset: braced for the sting, protective of her barrier.
In her words: "my skin reacts to everything." · "BP dries me out in two days." · "my barrier is shot."
Core fear: it'll burn, strip, or thin skin that's already fragile.
Tried: gentle stuff (breaks her out) and harsh stuff (burns) — stuck between both.
Angle: gentle / barrier-safe / won't strip.
Sub: pH-5.5, no synthetic fragrance, with squalane + hyaluronic putting moisture back — it clears without stripping. One phase is literally moisture going back in.
Lead with: the "don't-strip" mechanism (pH-5.5 cleanse, HA/squalane) + sensitive-skin testimonials.
Flip: "the first acne thing that didn't make my face hurt" · patch-test reassurance · the vitamin C won't sting.
CTA: "See the gentle system →"
Breaking out at 47 and dry at the same time? You're not doing skincare wrong — perimenopause changed the rules. The gentle 4-phase system that clears hormonal, cystic breakouts without stripping grown-up skin. No spiro. No Accutane. 60-day money-back — keep the bonus gummies either way.
Volume, tiers, rising trends, and the answer-engine question set — data pulled 2026-06-30.
"Perimenopausal acne" is a precise avatar term but a tiny search term (261/mo). Lead SEO with the high-volume heads + an "over 40 / for women" qualifier, and keep perimenopause as the emotional angle in the body copy. Don't make the niche term carry discoverability.
| Keyword | Amazon vol / mo | Role |
|---|---|---|
| cystic acne | 13,800 | Head — title, H1/H2 |
| hormonal acne | 2,992 | Head — title, H1/H2 |
| hormonal acne treatment | 1,383 | Head |
| adult acne | 822 | Head |
| perimenopause acne | 261 | Qualifier / angle |
| jawline acne | 187 | Qualifier |
| menopausal acne | 112 | Qualifier |
hormonal acne · cystic acne · hormonal acne treatment for women · adult acne treatment for women · for mature women
perimenopause acne · menopausal acne · hormonal jawline acne · chin and jawline acne · acne treatment for women over 40 · cystic acne perimenopause
best skincare for hormonal acne · hormonal acne skincare routine / set · best cleanser for hormonal acne · adult acne skincare system · menopause acne skincare set
second puberty · breaking out and drying out at the same time · acne treatment that won't strip your barrier · skin that's cystic and dry at once
The direct-response machinery behind the landing page — the mechanisms that move a jaded, tried-everything woman from "another one of these" to "add to cart." Every block earns its place; nothing is decoration.
| Scroll zone | Job | Mechanisms firing |
|---|---|---|
| Above the fold | Stop the scroll, identify her | Emotion-led hook · double-bind promise · trust badges — PER-HERO-EMOTION, PSY-IDENTIFICATION, SP-REVIEWS |
| POV story & education | Build pain past her threshold | First-person story · problem-of-the-problem · educate the WHY — PS-POV, pain-threshold, PER-MECHANISM (seed) |
| The kill-list | Pre-empt "I've tried everything" | List & kill every prior solution · two-buckets reframe — PS-CHAIN, PSY-CONTRAST |
| Discovery & reveal (~60% scroll) | Introduce the new mechanism | Skeptic-writer discovery · 3 criteria · product reveal — PER-MECHANISM, PER-INGREDIENT, PS-AUTHORITY |
| Proof | Make the skeptic believe | Before/afters · 1:1 objection testimonials · press & expert wall · founder — SP-BEFOREAFTER, SP-TESTIMONIAL, SP-EXPERT, PER-PRESS, PER-ORIGIN |
| Risk reversal | Remove the last excuse | 60-day money-back · keep-the-gummies — PER-RISKREVERSAL, PSY-LOSS, PSY-RECIPROCITY |
| The close | Force the decision | Two-roads framing · value stack · decoy ladder · honest scarcity · FAQ — AOV-VALUESTACK, AOV-DECOY, PSY-ANCHOR, URG-STOCK, PER-FAQ |
People tolerate pain up to a threshold, then act. We hit 3–5 core pains, reworded, until it's crossed — only then sell.
Hero-story arc (desired state → pain → decision → discovery → mechanism → proof). She's the hero; Livyond is the guide.
The narrator stays doubtful and "tests" the product — lowering the reader's guard and building trust step by step.
Product/price appears only after desire is built. Reveal too early and "it doesn't feel right."
End on a forced choice: keep the harsh/expensive status quo, or try risk-free. Paint option one negatively.
The page headline literally continues the ad hook — same pain, same avatar — so no message mismatch bleeds conversions.
| Mechanism | Code | How we use it here |
|---|---|---|
| Unique mechanism | PER-MECHANISM | "Clears without stripping" — soursop calm + niacinamide/glycolic/zinc at pH 5.5. The new vehicle a Stage-5 market hasn't heard. |
| Comparison table | PER-COMPARISON | Systemic drugs vs harsh topicals vs Livyond — we win every row honestly. |
| Ingredient → benefit | PER-INGREDIENT | Real actives + study numbers (ORAC 18,000, TEWL −22.4%) for the ingredient-literate skeptic. |
| Risk reversal | PER-RISKREVERSAL | 60-day money-back, no forms, keep the gummies. Framed as confidence, never "guaranteed results." |
| Objection testimonials | SP-TESTIMONIAL | Each review kills ONE objection (burns / internal / overpriced / prescription / speed / too-many-actives). |
| Expert + press wall | SP-EXPERT · PER-PRESS | Chemist + aesthetician + MD, and Marie Claire/Byrdie/NewBeauty — authority for a distrustful buyer. |
| Founder origin | PER-ORIGIN | Amy Lacey (Cali'flour) — vulnerability + credibility = the trust engine (~+23% founder-page lift). |
| Value stack + anchor | AOV-VALUESTACK · PSY-ANCHOR | $299.86 itemized → $97, so the price reads as relief. |
| Decoy ladder | AOV-DECOY | Core / Full (most-popular) / 2-System / Subscribe-default — the middle carries AOV. |
| Honest scarcity | URG-STOCK · PSY-SCARCITY | Real supply limit (soursop is harvested, not synthesized). No fake timer — fake urgency erodes hard-won trust. |
| Sticky ATC + single CTA | CART-STICKY | One soft CTA ("Start the protocol"), repeated after reveal / proof / guarantee, sticky on mobile. |
Two engines now decide who sees this page: classic Google search, and AI answer engines (ChatGPT, Perplexity, Google AI Overviews). Winning both means structuring the page around the exact questions people ask — and giving machines the context to quote us.
Ranks pages. Wants the head keywords in title/H1/H2, clean structure, real reviews, speed. Demand lives in "hormonal acne" (2,992/mo) and "cystic acne" (13,800/mo) — not the niche "perimenopausal acne" (261).
Quote passages. Want direct answers to real questions, structured data, named entities, and citable evidence. That's what the FAQ + schema below deliver.
| Slot | What goes there |
|---|---|
| <title> / meta | Head + qualifier — "Hormonal & cystic acne skincare for skin over 40 · Livyond" |
| H1 (on-page) | The emotional double-bind hook (for conversion); the keyword lives in the title tag + an early H2 |
| Early H2 | "A skincare system for hormonal & cystic acne on skin over 40" |
| Subheads / PDP | Commercial modifiers — best skincare for hormonal acne, hormonal acne routine, cleanser… |
| FAQ | Exact People-Also-Ask phrasing (below) + FAQPage schema |
Question = exact search phrasing. Use the real PAA wording verbatim as the H3.
Answer = direct first, 40–60 words. Put the answer in sentence one (AI lifts the first sentence), then one supporting sentence carrying the entity + mechanism. No preamble.
Then mark it up. Wrap the set in FAQPage JSON-LD so engines parse Q→A pairs cleanly.
| Question (H3, verbatim) | Intent → section |
|---|---|
| Why am I suddenly getting acne in my 40s? | Informational — the hook |
| How do you get rid of hormonal acne from perimenopause? | Commercial — the system |
| How do you treat hormonal acne in your 40s without spironolactone? | Commercial — the kill-list |
| What does perimenopausal acne look like? | Informational — self-ID |
| Why is my acne not going away? | Frustration — the double-bind |
| How long does it take to clear? | Commercial — the 60-day guarantee |
| Is hormonal acne internal — can a topical even help? | Objection — niacinamide |
| Schema type | Why it matters for AIO |
|---|---|
| FAQPage | Q→A pairs for AI Overviews + featured snippets |
| Product + Offer | Price, availability — the system as a defined entity |
| AggregateRating / Review | 4.9★ / 847 reviews as machine-readable trust |
| Organization + Person | Founder + expert team = E-E-A-T signals |
Explicitly name and define what the model reasons over: perimenopause, hormonal/cystic acne, the skin barrier, niacinamide, glycolic acid, zinc, soursop, the double-bind. Clear definitions = clean extraction.
Attach study numbers (ORAC 18,000, TEWL −22.4%, +239% collagen) and expert bylines. AI prefers claims it can source.
Informational (why) → education · Commercial (best/treat) → comparison + offer · Brand → founder. One page, all three intents mapped.
Tables, short lists, direct-answer sentences, and H2/H3 that mirror the questions. Engines lift structure faster than prose.
The research points to one funnel shape and a shortlist of named assets to test. Cold traffic never goes straight to the product — it earns the sale through a pre-sell that runs the kill-list and reveals the mechanism.
Cold / unaware traffic → advertorial or listicle pre-sell (educate + kill the alternatives) → the double-bind sales page → checkout with the AOV ladder → upsells + retargeting. Warmer / retargeted traffic can skip to the sales page. One angle per funnel; the pre-sell headline literally continues the ad.
Never send cold traffic straight to the product — pre-sell first.
Congruency: the ad hook = the pre-sell headline (same pain, same avatar).
Lead with the pain, prove with the mechanism, close on the risk-reversal.
Reveal the product at ~50–75% scroll — not before.
Test the hero first — it's the highest-leverage element on the page.
Honest scarcity · sticky ATC · one soft CTA, repeated.
Built assets (Catch-22, 5 Signs, 7 Reasons Spiro, the Double-Bind System, Clears, vs) open the live page. The rest open their strategic deep-build — funnel role, ad hooks, and the full block-by-block wireframe & copy.
| Asset | Type | ICP · Angle | Hook / description | Channel |
|---|---|---|---|---|
| The Skincare Catch-22 No One Warns You About at 45 | POV advertorial | ICP3 · double-bind | Breaking out AND drying out; kills one-sided fixes, reveals the 4-phase system. | Meta · native |
| I Did Not Agree to Puberty 2.0 | POV advertorial | ICP1 · second-puberty | Clear skin for 20 years → overnight cystic; discovers the calm-not-strip system. | Meta · Taboola |
| Why Your Acne Products Stopped Working After 40 | Editorial advertorial | ICP1/2 · mechanism | "It's not your routine" — the hormone + barrier WHY, then the fix. | Meta · Discovery |
| The Founder Who Couldn't Use "Strong" Skincare Either | Founder advertorial | Brand · ICP2 | Amy Lacey's autoimmune → soursop story; authority + vulnerability. | Meta · YouTube |
| My Dermatologist Kept Pushing Accutane. I Wanted Another Way. | POV advertorial | ICP2 · anti-Rx | No pill, no purge; runs the kill-list, discovers the gentle system. | Meta |
| 5 Signs Your "Acne" Is Actually Perimenopause | Listicle | ICP1 · problem-aware | Self-diagnose the signs → what finally helps. | TikTok · Meta |
| 7 Reasons Women Over 40 Are Quitting Spironolactone for This | Listicle / comparison | ICP2 · anti-Rx | Social-proofed reasons to switch off the pill. | Meta |
| 9 Hormonal-Acne Fixes, Ranked by What Actually Works After 40 | Kill-list listicle | ICP2 · proof | The honest scorecard — every option, why it fails, what wins. | Meta · Google |
| The 4-Minute Routine for Skin That Breaks Out AND Dries Out | VSL | Cold · double-bind | Walks the mechanism + proof; for colder, less-aware traffic. | YouTube · Meta |
| What's Really Causing Your Breakouts After 40? (2-min quiz) | Quiz funnel | Cold · all ICPs | Diagnostic → personalized result → matched routine + offer. | Meta · email |
| The Double-Bind System (main sales page) | Hybrid sales page | All ICPs | The core conversion page — advertorial → buy-on-page (Copy V2). | All (destination) |
| Clears Without Stripping | Landing variant | ICP3 · gentle | Sensitive / reactive-skin focused; barrier-safe proof. | Meta retargeting |
| Livyond vs Spironolactone vs Retinoids | Comparison landing | ICP2 · bottom-funnel | Honest head-to-head for high-intent searchers. | Google · retargeting |
All prices to confirm — figures shown are the recommended structure.
| In the box | Value |
|---|---|
| Phase 01 — Purifying Cleanser | $59.99 |
| Phase 02 — Vitamin C Brightening Serum | $49.99 |
| Phase 03 — Hyaluronic Restoration Cream | $49.99 |
| Phase 04 — Firming Cream | $49.99 |
| Bonus: Cell + Immunity Gummies ×2 | $49.90 |
| Free Express Shipping | $10.00 |
| 300 Loyalty Points | $30.00 |
| Total value | $299.86 |
At ~$5–6 COGS per product, every tier is profitable on the first order at realistic acquisition costs — reorders and subscribe are pure upside. That's the "make money on the first sale" structure that lets you outbid competitors on ad spend.
| Tier | Price | Est. COGS | Gross margin | Contribution* | Break-even CPA |
|---|---|---|---|---|---|
| Acne Core (2 products) | $49 | ~$11 | ~78% | ~$30 | up to ~$30 |
| Full System (4 + 2 gummies) | $97 | ~$33 | ~66% | ~$53 | up to ~$53 |
| 2 Systems | $169 | ~$66 | ~61% | ~$88 | up to ~$88 |
Use the full system for 60 days. If your skin isn't showing the calmer, settled look described — email us and get your money back. No forms, no return shipping. Keep the bonus gummies either way.
Stated precisely: this is a money-back guarantee, not a promise of specific results. Skin is individual; nobody honest can guarantee an outcome. The financial risk is off her shoulders — that is the reversal.
Pain-led double-bind → desire payoff ("get the woman in the mirror back") → offer-led close (anti-prescription, no side effects, guaranteed money-back). Opens by naming the failed solutions and the double-bind for the Stage-5 jaded reader, establishes the fresh "why this is different" (soursop new mechanism), then promises.
"Breaking out and drying out at the same time? You're not doing skincare wrong — your skin changed the rules."
Subhead carries the studied actives (niacinamide, glycolic, zinc) + soursop + "no spiro, no Accutane, no wait-4-months-and-pray."
A cold-eyed rating of the whole strategy, section by section — with the risks that could sink it and the moves that raise the odds.
The strategy is sound and genuinely differentiated: a real, rising, under-served market, an ownable wedge (the double-bind), and — with COGS at ~$5–6/unit — a model that’s profitable on the first order (66–78% margins). The $49 acne-core hardens product-fit and lowers CPA, and the funnel + messaging are execution-ready. Only two levers stay capped until you supply external inputs — real acne before/afters (proof) and a legal sign-off (compliance) — and both can run in parallel, not as a gate.
| Dimension | Score | The read | |
|---|---|---|---|
| Customer insight (VOC) | 90 | 330 Reddit + Quora, frequency-ranked. The deepest asset in the deck. | |
| Differentiation (double-bind wedge) | 88 | Ownable, under-served, and hard for a competitor to copy overnight. | |
| Messaging & angle | 88 | VOC-grounded, with ICPs and hero headlines ready to test. | |
| Offer & unit economics | 86 | COGS ~$5–6/unit → 66–78% gross margins and a first-order-profitable model, plus a $49 → $97 → $169 → subscribe ladder. Now a strength. | |
| Funnel readiness | 85 | Architecture + sales-page copy + 13 named assets + the AOV ladder all defined. Only the 2 priority pre-sells left to draft. | |
| Product–problem fit (mechanism) | 84 | The $49 acne-core (niacinamide Serum + glycolic Cleanser) is the acne-optimized pair — sidesteps the coconut-oil cream and most citrus-EO exposure. Full system stays the "complete" upgrade. | |
| Market opportunity & size | 84 | ~7M TAM, rising trend, and now a margin structure that makes the opportunity capturable. Demand data still Amazon-proxy. | |
| Search demand & discoverability | 84 | Strong in hormonal/cystic + a clear SEO/AIO plan (FAQ, schema, intent map). Google absolute volume still to confirm via Keyword Planner. | |
| Execution readiness | 84 | Copy, brief, offer, ladder, and funnel all defined. Remaining: build the page + run the proof trial. | |
| Compliance & regulatory risk | 80 | Internal tightening pass done (cosmetic rails, patch-test/phototoxic/FDA, no cure/disease). Still wants a formal legal sign-off on the acne claims. | |
| Proof & evidence readiness | 78 | Existing proof marshalled — 4.9★/847 reviews, 20k customers, reorder rate, 3-expert team, supplier studies, press. Acne-specific before/afters are the one remaining gap (run the trial). |
Ship the double-bind sales page + two pre-sells to a small test budget now. In parallel: (1) run a 20–30 woman 8-week trial to bank real before/afters + reviews, and (2) get a compliance sign-off on the acne claims. Default subscribe to capture the LTV. Then kill or scale on first-order ROAS + LTV:CAC — the ~66–78% margins already give you the room.
Living Beyond — Formulated with Purpose
Strong enough for the cyst. Gentle enough for skin that's pushing 50 and reacts to everything. The only column that wins every row honestly — because it's the only one built for the double-bind.
ktZlKcZKHC49mJuGx, ~330 usable items across r/Perimenopause · r/Menopause · r/SkincareAddiction · r/30PlusSkinCare · r/hormonalacne; 86 curated verbatim quotes); Livyond Ingredient Reference Guide (supplier study data); Amazon + Google keyword pulls (Apify, 2026-06-30); Livyond brand system, Phase-1 VOC playbook, and Peri-Acne Page Copy V2. Pricing and press logos marked to-confirm.
A first-person, confessional advertorial that names the exact moment clear skin turned on a 45-year-old woman — then reframes it from “my routine broke” to “my hormones changed the rules,” so a cold, problem-aware reader arrives at the sales page already believing the double-bind is the real enemy.
This is the cold-traffic on-ramp for ICP1 — the woman who has never had an acne “solution” identity because she never needed one. She isn’t comparison-shopping spironolactone; she is confused and a little ashamed that a face that behaved for two decades suddenly won’t. A hard product ad would bounce her — she isn’t looking for a serum, she’s looking for an explanation. The POV story format lets a stranger’s voice say the thing she’s too embarrassed to say out loud, then hands her the one belief the whole funnel depends on: this is hormonal, it’s the double-bind (breaking out AND drying out at once), and the fix has to calm without stripping. It must NOT sell hard; its only job is to convert a scroll into a warm, self-identified reader who clicks through to the Double-Bind sales page already primed.
I had clear skin for 20 years. Then I turned 45 and woke up with the acne I never had as a teenager. Nobody warned me this was part of it.
I did not agree to a puberty 2.0. Cystic breakouts AND dry, stinging skin — at the same time. Here’s what my derm never explained.
Why is a 45-year-old woman breaking out like she’s 13 — while her skin is also thinner and drier than ever? The answer isn’t your routine.
Editorial banner style, not an ad. Byline (“Written by [First name], 46”) + read-time. Image = a real, un-retouched woman ~45 in bathroom light, no product in frame. NO price, NO product. Continues the ad word-for-word (“puberty 2.0”) for scent-match. A/B test headline vs. Hook-C question form.
First-person, present, no hype. This paragraph does the identification work — if ICP1 doesn’t see herself here, she leaves. Keep the “I was the friend people asked” beat; it’s the exact ego-loss ICP1 grieves.
Pains are reworded from real VOC (chin cysts / mark for months / mirror avoidance / dry + breaking out). The final bullet plants the double-bind early so the reveal in block 05 lands as recognition, not a pitch. Compliant: “the inflamed look,” never “inflammation” as a condition.
“They just push Accutane, which I don’t want or throw new creams at me.” — r/Menopause
Honest kill-list: harsh cleansers (strip), “clean” brands (do nothing), Rx/derm (side-effect fear, right-but-not-for-me). REAL verbatim quote #1, source-tagged. Do not disparage spironolactone/tretinoin outright — ICP2 crosses over; frame as “not what I wanted,” not “they don’t work.”
“This really is like second puberty, but far worse.” — r/Perimenopause
The mechanism beat — the pivot from “my routine broke” to “my hormones changed the rules.” This is the belief the sales page inherits; write it as the a-ha, not a claim. REAL verbatim quote #2. Compliance: describe hormonal shift as context, no disease/treat language, no “cure.”
Mechanism, still pre-product. Niacinamide = efficacy hero; soursop = ownable brand hero. Keep “clears without stripping” verbatim — it’s the positioning line carried to the page. Cosmetic framing only: “the inflamed look,” “helps settle,” “supports the barrier.” No cancer, no ORAC-as-health-claim — antioxidant context only.
First product mention lands past ~55% scroll, only after the reader owns the mechanism. Lead with Acne Core ($49, low-CPA entry), mention Full System as an option, don’t stack the ladder here — the sales page does that. First small product image appears here, not before. Honesty rail: Firming Cream (coconut oil) is deliberately NOT pitched as the acne step.
“I feel like a teenager again. My skin had been clear for years… And now, suddenly…. It’s out of control.” — r/Perimenopause
REAL verbatim quote #3, source-tagged — chosen because it’s ICP1’s exact “I was clear, now I’m not” identity. Before/afters are SLOTS to fill with client-owned images. All stats from proof bank; press logos marked to-confirm. No invented reviews.
Soft offer — this is a pre-sell, not the sales page, so no price stack, no urgency timers, no full ladder. Risk reversal stated as money-back (60-day, keep the gummies), NEVER “guaranteed results.” Imply the standard FDA-style cosmetic disclaimer sits in the footer.
Single soft CTA, curiosity + congruency (repeats “double-bind” and “clears without stripping” verbatim). Button, not “buy now” — it’s a “keep reading” ask to the Double-Bind sales page. A/B test CTA copy: “See how it works” vs. “Read the full story.”
The CTA hands off to the Double-Bind sales page with zero message-break: same avatar (clear-for-20-years, blindsided at 45), same enemy (breaking out AND drying out), same promise (“clears without stripping”). The advertorial has already done the hard belief-shift — hormonal, not your routine — so the page opens warm and can go straight to mechanism depth, the full offer ladder (Acne Core $49 → Full System $97 → 2 Systems $169), and stacked proof. Carry the reader in mid-conviction; do not re-argue the problem.
Primary KPI: CTR from advertorial to the Double-Bind sales page (click-through rate on the block-10 CTA), and downstream page-view-to-add-to-cart of that traffic vs. cold-direct.
Watch: Scroll depth to the block-05 reveal and to the block-07 product intro — if readers drop before the reveal, the open/pain (blocks 02–03) isn’t identifying ICP1 hard enough.
First test: The headline/scent-match — “I Did Not Agree to Puberty 2.0” (identity) vs. the Hook-C question form (“Why is a 45-year-old breaking out like she’s 13?”). Winner sets the ad-to-advertorial congruency for the whole ICP1 buy.
This is one of the strongest ICP–format fits in the funnel: the “I did not agree to puberty 2.0” identity is a near-verbatim VOC line, and a confessional POV is exactly right for a problem-aware, not-solution-aware cold reader who wants an explanation before an offer. The score is held out of the high 80s by two honest gaps — the real before/afters that anchor the “without stripping” half of the promise are still slots, and nothing has legal sign-off yet on the soursop/perimenopause framing. The single biggest lever is landing the reveal (block 05): if the reader owns “it’s the double-bind, not my routine” before the product appears, everything downstream compounds; the main risk is a compliance drift from cosmetic language into implied hormonal treatment.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 90 | Massive, loud, under-served demand — “second puberty” and “nothing works” are dominant VOC threads; ICP1 is the largest, least-defended segment. |
| Message–market match (angle) | 88 | Headline is a near-verbatim VOC quote; the double-bind names a pain no competitor addresses. Ad → advertorial → page promise stay congruent. |
| Awareness & sophistication fit | 85 | POV story is the correct vehicle for problem-aware/not-solution-aware; new-mechanism + identification satisfies a Stage 4–5 jaded reader without a plain claim. |
| Proof sufficiency | 72 | Capped — real before/afters pending. Strong review count, press (to-confirm) and real VOC quotes carry it, but visual proof for “without stripping” is still slots. |
| Offer & economics fit | 80 | Acne Core $49 is a clean low-CPA entry congruent with the two-step story; 60-day money-back + keep-gummies lowers friction. Pre-sell correctly defers the full ladder. |
| Compliance risk | 76 | Capped — no legal sign-off yet. Copy holds cosmetic framing (“the inflamed look,” “helps settle”) and avoids cure/cancer, but soursop + perimenopause framing needs review; EO/photosensitivity note belongs in the footer. |
| Production feasibility & cost | 84 | Text-first editorial advertorial is cheap and fast to produce; the only real dependencies are client-owned before/after imagery and confirmed press logos. |
| Channel fit | 82 | Long-form confessional advertorial is native to Taboola and works as a Meta pre-sell landing; the identity hook is a strong thumb-stopper for the 40–55 female target. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
The flagship cold pre-sell — a first-person editorial that names the double-bind (breaking out AND drying out at once), kills every one-sided fix, then hands a warm, belief-shifted reader to the sales page.
This is the anchor pre-sell for the coldest, most jaded reader — the woman whose skin is breaking out AND stinging, flaking and red at the same time, who has already been burned by harsh acne products. Native editorial is the right format because a Stage 4–5 skeptic will reject a direct product ad on sight; she will read a story that finally names her exact problem. Its one job is to shift a single belief: “my problem isn’t acne OR dryness — it’s the double-bind, and every product I’ve tried forced me to pick a side.” Once that lands, it hands the sales page a reader who is no longer comparing acne products — she’s looking for the one thing that clears without stripping.
“The cruelest part of skin at 45? It breaks out AND dries out at the same time — and every product makes you choose which one to fix.”
“I was burning my face off with acne actives to stop the breakouts — and the breakouts got worse. Turns out I was treating the wrong problem.”
“Acne products stripped my skin raw. Moisturizers clogged it. Nobody warned me perimenopause skin needs both at once.”
Editorial byline treatment (“First-person · 6 min read”), a real 40–55 woman’s face at natural, non-glam close-up — visible texture, not airbrushed. NO product, NO logo above the fold. Headline continues the ad verbatim. A/B test: “Catch-22” vs “The Double-Bind” in the headline noun.
One tight avatar-recognition beat. Mirror the “clear for 20 years, then chaos” VOC frame exactly — this is the recognition trigger that earns the scroll.
Pains reworded from real VOC (“too deep for hydrocolloid,” pimple patches at 47, showers/sunscreen flaring, mirror-avoidance with dimmed lighting). Keep the LAST bullet as the pivot — it’s the setup for the double-bind reveal.
This is the credibility engine for a Stage 4–5 reader. Be scrupulously honest — concede spiro/tret WORK for many (never trash the Rx path), so the reader trusts the one thing we’re about to claim. Compliance: no disease/cure language; frame Rx as “not for me,” not “dangerous.”
The intellectual turn — the “aha” that reframes her whole history as one coherent problem, not personal failure. This is the belief shift the whole page exists to create. Still NO product named. Compliance: “inflamed / flares” not “inflammation cure.”
Name the mechanism (calm-not-strip) and the efficacy hero (niacinamide) before the product — sell the mechanism, then reveal the vehicle. Soursop stays as brand-hero flavor only; NEVER any cancer/health claim. Cosmetic language throughout.
First product mention past the halfway mark. HONESTY RAIL: label the Firming Cream a NIGHT/OPTIONAL step (contains coconut oil, comedogenic) — do NOT put it on the acne-direct path. Micro-disclosure near actives: “no synthetic fragrance; contains natural citrus oils — patch-test and avoid direct sun after use.” NEVER say “fragrance-free.” Soft inline product shot (the 4 bottles), not a hard buy-box yet.
Quotes are REAL verbatim VOC (source-tagged). Insert the 5 client-owned acne before/after images here as captioned slots (“Week 0 → Week 8, unretouched”) — do NOT invent results copy. Press row (Marie Claire / Byrdie / NewBeauty) [confirm logos]. Star rating [confirm live count].
AOV ladder = anchor the Full System against $299.86 (PSY-ANCHOR / AOV-TIERED). Subscribe-and-save mention optional here. Risk reversal is 60-day money-back, keep the gummies — NEVER “guaranteed results.” This is a soft in-editorial offer; the hard buy-box lives on the sales page.
Single CTA, benefit-framed, no discount-shouting. Button routes to the Double-Bind sales page with the SAME promise (“clears without stripping”) above its fold. Add a subtle FTC-style disclaimer footer (“These statements have not been evaluated… not intended to diagnose, treat, cure or prevent any disease. Individual results vary.”).
The CTA carries the reader across on identical language: this advertorial ends on “built for both,” and the sales page opens on “Clears without stripping” — same promise, same double-bind avatar, same calm-not-strip mechanism. Because the reader arrives already believing her problem is the double-bind (not plain acne), the sales page skips re-education and goes straight to proof, the 4-phase system, and the offer ladder. No message reset, no congruency gap — the temperature only rises.
Primary KPI: CTR from advertorial to the Double-Bind sales page (click-through on the block-10 CTA), and downstream cost-per-acquisition of readers who arrive via this path.
Watch: Scroll depth to the reveal (block 05) and to the product intro (block 07) — if readers drop before 05, the double-bind isn’t landing; if they hit 07 but don’t click, the offer bridge is weak.
First test: The hero headline noun — “Catch-22” vs “The Double-Bind.” One variable, held against the same body. Winner becomes the locked ad hook + page promise.
This is the strongest asset in the funnel because the angle is perfectly matched to the reader: the double-bind is a named, unserved problem with dense VOC support, and native editorial is the right vehicle for a Stage 4–5 skeptic. The single biggest lever is proof — the moment real, unretouched before/afters drop into block 08, the score jumps into the high 80s. The main risk is compliance: soursop is FTC/FDA-sensitive and there is no legal sign-off yet, so every line must stay cosmetic and the disclaimer must ship.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 92 | Perimenopausal acne is a large, growing, under-served segment; the double-bind cluster is one of the densest, most emotional threads in the VOC. Real demand, actively searching. |
| Message–market match (angle) | 90 | “Clears without stripping” names the exact unserved problem ICP3 lives; ad hook = pre-sell headline = page promise. Congruent end to end. |
| Awareness & sophistication fit | 85 | Problem-aware reader, Stage 4–5. The new-mechanism reveal + honest kill-list is the correct Carl move; native editorial disarms the jaded skeptic. |
| Proof sufficiency | 78 | Capped — real before/afters pending. Strong VOC quotes + 4.9★/847/20,000+ carry it, but the client-owned before/after slots are empty and press logos are [confirm]. |
| Offer & economics fit | 80 | Acne Core $49 is a clean low-CPA entry; Full System $97 anchored on $299.86 gives real AOV headroom; 60-day keep-the-gummies reversal fits a burned buyer. Cold-CPA on a long-read is the open question. |
| Compliance risk | 72 | Capped — no legal sign-off yet. Soursop is FTC/FDA-sensitive; copy stays cosmetic and dodges disease/cure language, but coconut-oil and citrus-EO disclosures plus the FDA-style disclaimer must be verified live before spend. |
| Production feasibility & cost | 82 | Copy-and-layout advertorial — cheap to build. Gated only on sourcing authentic 40–55 imagery and the 5 real before/after assets; no video or complex production needed. |
| Channel fit | 84 | Native in-feed advertorial is a proven Meta cold-traffic format for skeptical, story-driven buyers; long-read suits the problem’s emotional weight. Watch Meta’s scrutiny of skin/health creative. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
A third-person, authority-voiced explainer that reframes the problem — it’s not your routine, it’s a hormone shift your old products were never built for — and pre-sells the mechanism before the click.
This is the cold-traffic mechanism piece for a Stage 4–5 buyer who has already tried everything and no longer believes a product claim. It works because it doesn’t sell — it explains. The editorial, third-person “here’s the science” register buys back credibility that founder-POV and testimonial angles have burned, and it does the one job that matters at this awareness stage: shift the belief from “I’m using the wrong products” to “my skin changed underneath me, so products that strip now backfire.” Once the reader accepts declining estrogen → relative androgen dominance + a thinning barrier as the real cause, the double-bind (“clears without stripping”) becomes the obvious answer, and the click to the sales page is a logical next step, not a leap of faith.
“If your acne products stopped working after 40, it’s not your routine. Dermatologists point to a hormone shift most women are never warned about — and why the products that once worked now backfire.”
“Breaking out like a teenager — but your skin is dry, thin and stinging at the same time? There’s a reason the harsh stuff makes it worse. Here’s the mechanism.”
“Why ‘more actives, stronger scrub, another retinoid’ is exactly the wrong move for perimenopausal skin — and what skin scientists say to do instead.”
Kicker eyebrow above headline: “THE SCIENCE · Skin & Perimenopause.” No brand logo up top — editorial masthead feel (byline, read-time). Image: neutral, documentary close-up of skin texture / a bathroom counter of half-used products — NOT a glam beauty shot. Byline builds authority (“Reviewed against dermatology sources”). No CTA above the fold.
Third-person throughout — “one woman,” “many women,” never “I.” This block establishes the journalist is describing a documented pattern, not a single anecdote. Sets up the first verbatim quote.
Pull-quote styling, large, set off from body. Real verbatim (quote 1 of 3). “Why didn’t our moms warn us” is the emotional spine of the whole piece — it primes the “here’s what no one told you” payoff in the next section.
This is the load-bearing block — the mechanism the entire ad rests on. Keep it plain-English and cosmetic-framed: “the look of,” “oil balance,” “barrier” — NO disease/treat/cure language, no hormone-therapy medical claims. Optional simple 2-panel diagram: estrogen line falling / androgen influence rising relative to it. A/B a one-line “in short” summary vs. no summary.
Honesty-over-hype block. This is the “false trails” beat re-cast as mechanism, not a smear on prescriptions — keep it respectful (spiro/tret work for many; the point is the drying, not that they’re bad). Leads into quote 2. Compliance: describe the drying/irritation pattern cosmetically; do not disparage any drug by name as unsafe.
Real verbatim (quote 2 of 3). “Burning my face off with harsh actives” is the exact felt-experience of the mechanism just explained — it lets the reader recognise herself in the science. Keep as a second pull-quote, visually consistent with block 03.
The pivot from “why it’s failing” to “what would actually work.” This names the double-bind explicitly and hands the reader the buying criteria before any brand appears. Still no product, still no price — we’re at ~55% scroll. This is the belief the sales page will inherit.
First brand mention lands at ~60% — inside the 50–75% window. Introduce as one of the options that solves the criteria set in block 07, not as “the miracle.” Lead with niacinamide (efficacy hero), soursop as the ownable brand note. Compliance: cosmetic verbs only (“helps balance,” “the inflamed look”), NEVER “treats.” Do not surface the Firming Cream / coconut-oil step here — keep the pre-sell to the cleanser + serum acne-direct story.
Real verbatim (quote 3 of 3) — it voices exactly the buyer this piece is written for and pays off “without stripping.” Insert ONE real before/after slot here (client-owned, 5 exist) — do not invent specifics or timelines. Keep proof understated to preserve editorial tone; heavy stars/badges belong on the sales page, not here.
Editorial-style text CTA, not a hard “BUY NOW” — congruency matters more than urgency at cold. No price shown; the click is to learn, not to buy. Add a light FDA-style cosmetic disclaimer footer (“These statements have not been evaluated…” imply present) + patch-test / photosensitivity note if any product visuals appear. A/B the CTA label: “Read how it works” vs. “See why it clears without stripping.”
The CTA carries the exact promise the reader just accepted — “clears without stripping” — straight onto the Double-Bind sales page, which must open on that same line and the same avatar (40+, tried-everything, dry-and-breaking-out). No new angle, no bait-and-switch: the mechanism is already sold, so the page’s job is to prove and convert (system breakdown, ingredient detail, before/afters, offer ladder, 60-day money-back). The pre-sell hands off belief; the page hands off the offer.
Primary KPI: Cost per click-to-sales-page from cold Meta / Discovery, then downstream CVR & CPA on that traffic. The advertorial’s job is qualified clicks that convert, not cheap clicks.
Watch: Scroll depth to the mechanism block (04) and to product intro (~60%). If readers drop before the mechanism lands, the hook/lead isn’t earning the read; if they read but don’t click, the close/CTA is weak.
First test: The lead framing — “It’s not your routine” (mechanism-led, current) vs. “Why the harsh stuff now makes it worse” (double-bind-led). Same body; test which counterintuitive opener wins the read on cold traffic.
Strong on the fundamentals that matter most for cold traffic: the demand is real and loud in VOC, and the mechanism-led editorial angle is the correct move for a Stage 4–5, burned-out buyer — this format sidesteps the “another product claim” wall better than any other in the funnel. The single biggest lever is proof: the mechanism is credible on paper but the piece leans on Reddit quotes and pending before/afters, so the reveal lands intellectually more than viscerally. The main risk is compliance — the estrogen/androgen mechanism copy is cosmetic-framed but has not had legal sign-off, and one sloppy edit toward “treats hormonal acne” would breach the rails.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 92 | Perimenopausal acne is a loud, under-served, growing segment; VOC shows “nothing works” and “why didn’t our moms warn us” as pervasive, high-intent pain. |
| Message–market match (angle) | 88 | “It’s not your routine” + the hormone-shift mechanism is the right unlock for a jaded buyer; the double-bind wedge is congruent hook→asset→page. |
| Awareness & sophistication fit | 86 | Editorial “the science” register is the correct Stage 4–5 play — new mechanism before claim. Risk: ICP1 (not solution-aware) may need more hand-holding than ICP2. |
| Proof sufficiency | 72 | Capped — real before/afters pending. Leans on Reddit VOC + star/press counts (some [confirm]); no owned clinical or dermatologist voice yet. |
| Offer & economics fit | 80 | Acne Core $49 is a clean low-CPA entry congruent with the cleanser+serum pre-sell; 60-day keep-the-gummies reversal de-risks. Advertorial defers price, protecting cold CVR. |
| Compliance risk | 74 | Mechanism copy is cosmetically framed and avoids disease/cancer language, but no legal sign-off; hormone-mechanism claims are the fragile point and need review + FDA-style disclaimer live. |
| Production feasibility & cost | 90 | Copy-driven long-form editorial + documentary-style stock/UGC; cheap and fast to build and iterate. Only real dependency is the before/after assets. |
| Channel fit | 82 | Advertorial pre-sell is a proven Meta / Discovery format for this demo; native-content feel suits the feed. Watch iOS attribution and creative fatigue on the hook. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
A first-person origin story from Amy Lacey — built to earn trust before it sells, by proving the founder lived the exact double-bind the reader is trapped in.
This is the pre-sell for the reader who has already tried the pharmacy aisle — spironolactone, tretinoin, birth control, a derm waving Accutane — and walked away with side effects, purging, or a face that stings. A plain product claim bounces off her; she needs a reason to believe someone finally understands. The founder story does one job: convert skepticism into identification. Amy didn’t formulate soursop skincare as a marketer chasing a trend — she built it because her own autoimmune, reactive skin couldn’t tolerate the harsh actives everyone kept pushing. Authority (she formulated the thing) plus vulnerability (she needed it first) is what makes a Stage 4–5 cynic lower her guard. It hands the sales page a warmed-up reader who already believes the mechanism is honest.
“I formulated a skincare line I couldn’t use. So I started over.” — the founder-confession open. Authority + vulnerability in one line.
“My own skin was too reactive for every ‘strong’ acne product on the market. Here’s what I built instead.”
“A derm told me to just push through the burning. As the person who makes skincare, I refused — and reformulated everything.”
Editorial, not ad-y. Byline “By Amy Lacey, Founder” + a real, unretouched headshot (not a glossy brand shot). No product visible above the fold — this is a letter, not a listing. A/B test the byline photo (candid vs. studio) for read-through.
Ground it in a scene, not a bio dump. Keep every fact beyond “autoimmune + reactive skin” in a [confirm] bracket — do not invent her age, diagnosis, or timeline. This is the identification beat: she is describing ICP2/ICP3’s exact reality.
3–5 reworded pains, drawn straight from VOC (patch adhesive, harsh actives, tight/raw skin). Set them as a scannable list. This is the mirror moment — she names their day so precisely they stop skimming.
Honest, not smug — concede each option works for someone. Never disparage prescriptions or imply Livyond replaces medical treatment (compliance). Frame the failure as fit, not fraud: none of it served her double-bind. Cite the real VOC quote in block 08 to back this.
The new-mechanism beat — the belief the whole page exists to install. Give the enemy a name (“strip vs. clog”) so the reader reframes every past failure as a category error, not her fault. This is the exact wedge the sales page will pay off.
Soursop = ownable brand hero; niacinamide = the efficacy hero — lead efficacy with niacinamide, let soursop carry the story. Cosmetic language only (“settles the inflamed look,” never “treats”). NEVER mention cancer re: soursop. No “fragrance-free” claim — if EO comes up later, say “no synthetic fragrance, patch-test advised.”
First product mention, held past the halfway point per advertorial anatomy. Introduce the SKU ladder softly (Acne Core $49 entry / Full System $97) — don’t hard-pitch price here; that’s the sales page’s job. Note the Firming Cream (coconut oil) is a night/optional step and stays OUT of the acne-direct pitch. First product photo appears here, not before.
Real verbatim VOC quotes used as social proof of the problem — they validate the double-bind, then the founder pivots to Livyond’s numbers. Slot the 5 real before/after images here (client-owned) — do not fabricate results copy. Press logos (Marie Claire, Byrdie, NewBeauty) [confirm logos]. 20,000+ / 847 / 4.9★ are existing claims; keep as-is or [confirm].
Risk reversal in the founder’s voice makes it feel personal, not corporate. 60-day money-back, keep the gummies — NEVER “guaranteed results.” Surface the ladder (Acne Core $49 / Full System $97 ★ / 2 Systems $169 / Subscribe & save) but let the sales page do the anchoring math. Include the FDA-style disclaimer near actives/claims.
Soft CTA into the Double-Bind sales page — signed “— Amy.” Test one CTA vs. a repeated CTA after blocks 07 and 09 for scrollers. Keep the promise line (“clears without stripping”) verbatim so the sales page headline matches.
The CTA carries the founder’s exact promise — “clears without stripping” — straight into the Double-Bind sales page headline, so there’s zero message-gap on click. The reader arrives already believing the mechanism (calm-not-strip, niacinamide + soursop) and already trusting the maker (she lived it). The sales page doesn’t re-argue the problem; it picks up warm at the offer, the full proof stack, and the AOV ladder. Same avatar (Rx refugee, reactive skin), same wedge, same voice.
Primary KPI: CTR from advertorial to the Double-Bind sales page (pre-sell efficiency), and downstream ROAS on that traffic vs. cold-to-page.
Watch: scroll depth to the ~55–60% product reveal (block 07) — if readers drop before it, the origin/pain beats (02–05) are too long. Also time-on-page as a trust proxy.
First test: the hero open (block 01) — founder-confession authority line (“I couldn’t use ‘strong’ skincare either”) vs. a pure vulnerability open (“My own skin was too reactive…”). One variable, one angle.
The founder-confession angle is an exceptional fit for a jaded, Rx-refugee ICP2 — authority + vulnerability is the highest-trust pre-sell format available, and the double-bind wedge lands hard against a Stage 4–5 market. The single biggest lever is Amy’s authenticity: this asset lives or dies on a real, unretouched founder portrait and true biographical detail (currently [confirm] slots), because a fabricated or glossy founder story will invert the trust it’s built to earn. The main risk is proof and compliance: real before/afters are still pending and there’s no legal sign-off on the cosmetic/soursop framing yet.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 92 | Perimenopausal/hormonal acne is a large, underserved, high-emotion market; VOC shows relentless “nothing works” and “reluctant to try anything harsher.” |
| Message–market match (angle) | 90 | Founder who couldn’t tolerate harsh actives = the exact ICP2/ICP3 reality; “clears without stripping” is a true new-mechanism answer to the double-bind. |
| Awareness & sophistication fit | 85 | Solution-aware, Stage 4–5 cynic needs mechanism + identification before a claim — the origin story delivers both. Slight risk of over-length before the reveal. |
| Proof sufficiency | 78 | Capped — real before/afters pending. Strong VOC quotes + 4.9★/847/20,000+ carry it, but the founder’s own before/after and verifiable bio are the missing keystones. |
| Offer & economics fit | 82 | Acne Core $49 low-CPA entry + Full System $97 ladder + keep-the-gummies reversal fit a pre-sell well; founder-voice risk reversal boosts perceived safety. |
| Compliance risk | 80 | Capped — no legal sign-off yet. Cosmetic framing, no cancer/soursop, no “guaranteed results,” EO/coconut liabilities handled — but the founder autoimmune narrative needs review to avoid implied medical claims. |
| Production feasibility & cost | 84 | Mostly copy + one authentic founder portrait + existing proof assets; low cost. Bottleneck is a genuine, cleared founder photo and confirmed bio, not production. |
| Channel fit | 86 | Long-form founder advertorial is native to Meta feed click-to-page and YouTube pre-roll/story ads; congruent hooks feed it cleanly. Needs a tight sub-15s video cut-down for cold. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
A first-person POV advertorial that meets the Rx refugee mid-decision — validates why she's hesitant about the pill route, then bridges her to a gentle, non-prescription system without disparaging medicine.
This is for the woman who has already been in the derm's office — she's tried or been offered spironolactone, tretinoin, birth control, and now Accutane, and she's flinching. The POV advertorial works for her because she trusts a peer's lived story over a brand's pitch; a founder-y first-person voice lowers her guard where a claim would raise it. The belief it must shift: “non-prescription = weak / won't work for hormonal acne.” It reframes her real problem as the double-bind (breaking out AND drying out), positions a calm-not-strip mechanism as the missing option between “harsh pill” and “does nothing,” and hands a warmed-up, self-identified reader to the Double-Bind sales page. Compliance rail: alternatives are described factually and respectfully — never medically disparaged, never claimed to replace treatment.
“My derm kept pushing Accutane. I wanted to clear my skin without the pill, the purge, and the dryness. Here's the route I found instead.”
“I'm 46. I didn't want another prescription with a side-effect list longer than the benefit. So I stopped looking for something stronger — and started looking for something gentler.”
“Every acne fix stripped my skin. Every moisturizer clogged it. Turns out the problem wasn't that I needed a harsher drug — it's that nothing was solving both at once.”
First-person, editorial layout (byline + “5 min read”, not a product banner). Lead image: a real-looking woman ~45–50 at a bathroom mirror, natural light, no glam. CTA lives further down — NO buy button above the fold. A/B test: “another way” vs “a gentler way” in the headline.
Establishes ICP2's exact age + trigger moment (the derm's office). Keep it specific and unglamorous. This is the “that's me” hook — scroll depth to here is the first health signal.
3–4 pains, reworded from VOC (chin/jawline cyclical cysts, makeup-over-sore-skin, “try one more” fatigue, “why didn't our moms warn us”). Keep cosmetic — “the inflamed look,” never medical claims.
CRITICAL compliance block. Each item: acknowledge it works for some → state a factual, personal reason it wasn't her fit. NEVER call a medicine unsafe/ineffective. This is what earns ICP2's trust — she's been talked down to; here she's respected. Pull the real “They just push Accutane, which I don't want” VOC energy without claiming it verbatim as the brand.
The wedge lands here. This is the “new problem” a Stage 4–5 market needs before a solution. Anchor the exact phrase “clears without stripping” — it becomes the page promise downstream. Pull-quote styling.
Efficacy hero = niacinamide (do the heavy lifting here); brand hero = soursop (name it, antioxidant framing ONLY — never cancer/health claims). Cosmetic verbs only: “calm / settle / the inflamed look.” This is the belief-shift: gentle can still be effective.
First product mention at ~60% scroll per anatomy. Lead with the low-CPA Acne Core $49, mention Full System as the upgrade. The honesty aside (EO photosensitivity + coconut-oil firming cream = night/optional) BUILDS trust with the most skeptical ICP — do not hide it. Never say “fragrance-free”; say “no synthetic fragrance.”
3 REAL verbatim VOC quotes (kept exact, source-tagged) — they mirror ICP2's anti-Rx / anti-harsh stance without the brand making claims. Below: 5 client-owned before/after slots [fill with real assets — do not invent specifics]. Press logos + rating strip. Imply FDA-style disclaimer nearby.
Anchor Full System against $299.86 value (PSY-ANCHOR/CONTRAST). $49 Core is the low-friction entry for cold ICP2. Risk reversal = 60-day money-back, keep the gummies. NEVER “guaranteed results.”
Soft, congruent handoff — restates “clears without stripping” and the respectful anti-Rx stance so the sales page feels like the same voice. CTA goes to the Double-Bind sales page, NOT straight to cart. A/B test CTA: “See how it works” vs “Try the Acne Core — $49”.
The closing CTA hands off to the Double-Bind sales page with total congruency: same avatar (Rx refugee, 40s–50s), same enemy (harsh strip-vs-clog trap), same promise (“clears without stripping”), same respectful anti-Rx tone. The advertorial does the belief-shift work (gentle can be effective; non-Rx is a legitimate route); the sales page inherits a pre-sold, self-identified reader and only needs to deepen mechanism, proof, and offer — not re-argue the premise. Do NOT jump to checkout from here; the destination is the page, so the offer ladder is introduced but not transacted.
Primary KPI: CTR from advertorial → Double-Bind sales page (and cost per landing-page click). Secondary: assisted CVR / ROAS on the ICP2 audience.
Watch: scroll depth to the Block 05 reveal and to the Block 07 product intro (~60%). If readers drop before the reveal, the pain/kill-list is too long; if they reach the offer but don't click, the bridge promise is off.
First test: the Block 04 kill-list framing — “respectful, works-for-some” tone vs a tighter “here's why each wasn't my fit” list. This block carries the anti-Rx trust; test it before the headline.
ICP2 is the sharpest-defined, highest-intent segment in this funnel — solution-aware women mid-decision at the derm's office — and the POV format plus respectful kill-list is exactly the trust move that converts them, which carries the score into GO territory. The single biggest lever is proof: swapping the placeholder before/afters for real, labeled acne results is what unlocks the next 8–10 points. The main risk is compliance — the anti-Rx angle lives one careless sentence away from disparaging medicine or implying treatment, so it must not ship without legal review.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 88 | Perimenopausal / hormonal acne is a large, growing, underserved US segment; VOC shows intense, repeated pain and active spending on Rx routes. |
| Message–market match (angle) | 86 | “Wanted another way” + the double-bind maps precisely onto ICP2's lived anti-Rx / anti-harsh stance; the kill-list mirrors real VOC language. |
| Awareness & sophistication fit | 85 | Solution-aware, Stage 4–5 reader gets a new mechanism (calm-not-strip) + identification before a claim — correct Carl doctrine for a jaded market. |
| Proof sufficiency | 78 | Capped — real before/afters pending; strong rating/count + real VOC quotes, but the persuasive before/after frames are still placeholder slots. |
| Offer & economics fit | 80 | $49 Acne Core is a low-CPA cold entry with a clean $97 upgrade path; 60-day keep-the-gummies reversal lowers first-purchase risk for skeptics. |
| Compliance risk | 72 | Anti-Rx angle is inherently sensitive — must describe medicines respectfully, avoid disease/treat language and “fragrance-free,” and clear legal before launch (no sign-off yet). |
| Production feasibility & cost | 84 | Editorial advertorial is cheap to produce — one writer, existing product shots, a lifestyle photo; only real dependency is sourcing genuine before/after assets. |
| Channel fit | 83 | Long-form POV advertorial is a proven Meta pre-sell format for a skeptical 40–55 female audience; feed + reels hooks feed it congruently. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
A scroll-stopping self-diagnosis listicle that reframes “random adult breakouts” as a hormonal shift — so a blindsided 40-something stops buying teen acne products and starts looking for the real fix.
This is the top-of-funnel diagnostic net for ICP1 — women who had clear skin for 20+ years and are now breaking out at 42–48, confused and embarrassed, blaming their “acne.” The listicle format works because it never sells first: it lets her privately count her own symptoms and arrive at the diagnosis herself (“if 3+ of these sound like you…”), which is far more persuasive than us telling her. The single belief it must shift: “This isn’t random acne — it’s hormonal, that’s why nothing off the teen-acne shelf has worked, and it needs a different kind of product.” It hands the newly-labeled reader to the Double-Bind sales page with a name for her problem and a reason to believe the old category failed her.
“If you’re 45 and suddenly have teenage acne AND wrinkles — it’s not your face, it’s your hormones. 5 signs it’s perimenopause ↓”
“Clear skin for 20 years… then it went wild like I was a teenager again. Turns out my ‘acne’ was actually this. See if 3+ of these sound like you.”
“Nobody warns you: perimenopause acne shows up on your chin, comes back every month, and won’t respond to normal acne products. Here’s how to tell if that’s you.”
Above the fold: no product, no logo-heavy branding — reads like an editorial/creator post, not an ad. The “if 3+ sound like you” line is the engagement contract; place it as its own emphasized paragraph. On TikTok this is the spoken VO over the first 3 seconds; on Meta it’s the primary text + first screen of the advertorial. A/B test headline “Actually Perimenopause” vs “Actually Hormonal.”
Visual: simple face-map graphic highlighting the chin/jaw zone (no real-model needed — illustration reads cleaner and avoids skin-claim risk). This is the highest-recognition sign — lead with it. Keep quotes verbatim with the subreddit tag for authenticity; do not paraphrase.
This is the identification beat — it names the “why now?” she’s been asking. Tie it to other peri symptoms (hot flashes, mood) so the hormonal frame clicks. Keep it cosmetic/observational — describe timing, never “treat” or diagnose a condition.
“Cyclical” is the diagnostic keyword — make sure it lands. This is where pain intensity peaks in the list; keep the language physical and specific (sore, deep, week-long, leaves a mark). Compliance: “the inflamed look,” never “inflammation” as a condition to treat.
THE pivot block — this is the wedge for the whole funnel. It reframes “my products aren’t working” as “no product was built for my actual problem,” which sets up the reveal. Bold “the double-bind” as a named enemy. Do NOT solve it here; just name it. This is the belief the sales page will pay off.
Closes the list on the “acne + aging” overlap unique to this ICP — reinforces that this needs a product built for mature, reactive skin, not a teen acne wash. This is the natural bridge into the tally + reveal.
The commitment cash-in: she’s privately said “yes” to 3+ signs, so this lands as confirmation, not a pitch. Absolves her (“you weren’t doing it wrong”) — removes shame, builds trust. Still no product. This is the ~55–60% scroll mark.
Mechanism = new-and-different, required for a Stage 4–5 market. Niacinamide = efficacy hero, soursop = ownable brand hero — both named. Keep to cosmetic verbs (“calms, settles, supports, evens”). This is the first moment the solution appears — roughly 65% scroll.
Product revealed only now (~70% scroll), per advertorial anatomy. Lead with the Acne Core pair (Cleanser + Serum) since it’s the low-CPA entry SKU. Honesty rail included: “no synthetic fragrance” (never “fragrance-free”), patch-test + photosensitivity note because of the citrus essential oils. Do not foreground the Firming Cream (coconut oil / comedogenic) in an acne asset.
Proof stack after the product intro. Use REAL before/afters only — slots to fill, do not fabricate specifics. Stats are from the proof bank; leave the [confirm] on press logos. On TikTok, swap the before/after for a UGC talking-head clip.
Ladder with Full System as the anchored recommended tier (PSY-ANCHOR via the $299.86 value stack). Risk reversal is money-back only — NEVER “guaranteed results.” For a cold listicle, lead the CTA toward Acne Core (lowest friction) but keep the ladder visible.
Soft CTA carries the “3+ signs” callback and the “double-bind” language straight into the sales page — congruency handoff. Single primary button; keep the promise identical to the sales-page hero.
The CTA hands off with the reader already self-labeled (“I counted 3+, it’s hormonal”) and already carrying the vocabulary the sales page opens with: the double-bind and clears without stripping. The sales-page hero must repeat that exact promise and speak to the same avatar (clear skin for decades, blindsided in her 40s) — no new angle, no re-education. The listicle sells the diagnosis; the page sells the system. Same woman, same words, next step.
Primary KPI: outbound CTR from listicle to the Double-Bind sales page (cold traffic quality), with cost-per-landing-page-view as the efficiency guardrail.
Watch: scroll depth to the reveal (block 07–08) — if readers drop before the tally, the 5 signs aren’t resonant enough; and read-time on Sign #4 (the double-bind pivot).
First test: the intro hook — “Actually Perimenopause” vs “Actually Hormonal” in the headline (some 40–42s don’t yet self-identify as perimenopausal). Then test order of Sign #1 (chin) vs Sign #4 (double-bind) as the lead sign.
Strong because demand is deafening and the self-diagnose listicle is the correct format for a problem-aware, not-solution-aware ICP1 — the “count 3+ signs” mechanic does the persuasion for us on cold TikTok/Meta. The single biggest lever is proof: the moment real 40–55 before/afters and a UGC talking-head clip drop in, CTR-to-page and belief both jump. The main risk is compliance drift — a Stage 4–5 hormonal-acne angle sits close to disease-claim territory, so every “calms / settles / the inflamed look” line needs legal sign-off before spend.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 92 | The VOC is overwhelming — “second puberty,” “nothing works,” chin/jaw cysts recur constantly. Huge, underserved, emotionally loud audience. |
| Message–market match (angle) | 86 | Reframing “acne” as hormonal is the exact belief-shift ICP1 needs; the double-bind wedge (Sign #4) is the differentiated hook. Loses points only because the payoff lives on the next page. |
| Awareness & sophistication fit | 84 | Listicle self-diagnosis is right for problem-aware/not-solution-aware; new mechanism (niacinamide + soursop) satisfies a jaded Stage 4–5 reader. Some 40–42s won’t yet self-ID as “perimenopausal” — hence the headline test. |
| Proof sufficiency | 72 | Capped — real before/afters pending. Stats (4.9★/847/20k+) and verbatim Reddit quotes carry it for now; press logos still [confirm]. Biggest single upgrade available. |
| Offer & economics fit | 80 | Acne Core $49 is a clean low-CPA cold entry; ladder + 60-day keep-the-gummies reversal is strong. Cold listicle traffic to a $49–$97 first purchase is a realistic ask. |
| Compliance risk | 74 | Capped — no legal sign-off yet. Hormonal-acne framing is claim-adjacent; copy stays cosmetic and flags no-synthetic-fragrance / patch-test / photosensitivity, but needs review before spend. |
| Production feasibility & cost | 82 | Listicle text + a face-map illustration + one UGC clip is cheap and fast to ship. Only real cost is sourcing genuine before/afters and a creator for the TikTok cut. |
| Channel fit | 80 | Strong TikTok/Meta fit — the 5-signs countdown is native short-form and swipeable advertorial. Slight drag: 12 blocks is long for TikTok, so the video cut must compress to signs + reveal + CTA. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
A social-proofed “reasons to switch” listicle that respects the medication women already trust — then names the one thing a pill was never built to fix, and hands the reader to the calm-not-strip system.
This is the flagship cold pre-sell for the Rx refugee — a woman who is already on, coming off, or side-eyeing spironolactone and is actively comparison-shopping a non-prescription route. Because spironolactone is the single most-loved solution in the VOC, the listicle must NOT trash it — that would insult the reader and break trust instantly. The job is to validate that spiro works for many, agree with her honest reasons to look for another way (the script, the potassium blood tests, side effects, the “stop if pregnant” problem, the diuretic effects, the rebound when you quit), and then re-frame the ONE gap no pill addresses: the double-bind of clearing skin while it’s also drying and reacting. The belief it must shift: “my only real options are a prescription or nothing.” It hands a warmed, self-selected, comparison-ready reader to the Double-Bind sales page.
“Spironolactone cleared my skin. Here are 7 honest reasons I still went looking for something else.”
“No script. No potassium blood tests. No ‘stop-if-pregnant.’ Why women over 40 are switching from the pill that works.”
“Spiro can clear the breakouts. It was never built to fix the dry, stinging, reactive skin that came with them.”
Editorial masthead look, not a product ad. Small byline (“Reviewed for the perimenopausal-skin community”). No product, no price visible. A/B the headline number (“7 Reasons” vs “The Honest List: 7 Reasons…”). CTA lives only at the reveal + close.
This block earns the right to be read by conceding spiro’s strength up front (reciprocity + disarms the skeptic). Sets the “honest, respectful” tone the whole compliance rail depends on.
Real verbatim #1. Frames dependency as friction, not danger. No medical claim — just describes the logistics of a prescription.
Real verbatim #2. Quote the reader, not a study — keeps it cosmetic-safe. “Non-systemic / topical” is the honest, ownable contrast (a cream doesn’t go through your bloodstream).
Real verbatim #3 & #4. Two contrasting voices show these are real reader experiences, not the brand editorializing. Report what people said; never state a medical warning as fact.
State the fact neutrally (it’s widely known, not a claim about our product). Frames our system as the “on your own terms” alternative without over-promising.
The “whole-body effect for a face problem” line is the recurring drumbeat that sets up the topical/localized contrast. Keep it light, not alarmist.
Loss-aversion beat. Careful language: “manages while you take it” is accurate and cosmetic-safe; we do NOT claim our system cures anything — we sell “skin that holds on its own” as an aspiration, not a guarantee.
The pivot block — the whole listicle exists to land here. Introduces the mechanism/wedge (the double-bind) as the gap even the best medication leaves open. Still no product; we’ve only named the real problem.
This is the ~55–60% scroll point. First reveal of the “this” — still positioned as a category/approach, not a hard product pitch yet. “Non-prescription / topical” ties every one of the 7 reasons together.
Splits the heroes exactly per brief: niacinamide = efficacy hero, soursop = ownable brand hero. Cosmetic verbs only (“balance / calm / the inflamed look / even out”). No disease language, no cure.
Product/price arrives at ~70% scroll (spec compliant). The honesty note about EO / photosensitivity / coconut-oil Firming Cream is baked in per the liability rail — NEVER “fragrance-free.” Builds trust with a jaded Stage 4–5 reader.
Reference the 5 real before/afters as slots to fill — do not invent specifics. Keep the count band tight. [confirm] flags stay until logos are verified. Captions describe appearance only.
Tiered anchor with Full System as the recommended middle (decoy math visible: $299.86 → $97). Risk reversal = 60-day money-back, keep the gummies — NEVER “guaranteed results.”
Soft CTA repeats the respectful frame (never bash spiro) and carries the exact double-bind promise into the sales page. Single primary button; secondary text link to Acne Core for the ready-to-buy skimmer.
The CTA hands off to the Double-Bind sales page with total congruency: same avatar (the Rx refugee looking for a non-prescription route), same promise (“Clears without stripping”), same mechanism (calm-not-strip; niacinamide efficacy + soursop brand hero). The sales page opens where the listicle left off — it should NOT re-argue against spironolactone; instead it deepens the double-bind mechanism and moves straight into the full offer ladder for a reader who has already self-selected as ready to switch.
Primary KPI: CTR from listicle to the Double-Bind sales page (self-selected, comparison-ready clicks), then page→checkout rate on that traffic.
Watch: Scroll depth to the Reason 7 / reveal (blocks 09–10). If readers drop before the double-bind pivot, the 7 reasons are dragging — tighten reasons 4–5. Also watch bounce on the honesty note (block 12) — it should build trust, not scare.
First test: The frame in blocks 01–02 — “quitting spironolactone” (bolder, higher CTR risk) vs a softer “looking beyond spironolactone / the honest list” (safer for the spiro-loving reader). Everything downstream depends on not alienating a reader who loves her medication.
The angle is a bullseye: spironolactone is the runaway #1 loved solution in the VOC, and this asset monetizes the exact friction those same threads voice — the script, the potassium tests, the side effects, the rebound — without insulting the medication. The single biggest lever is proof: real acne before/afters aren’t published yet, and a Stage 4–5 Rx refugee will not convert on stock imagery alone. The main risk is brand-safety and compliance — naming a widely-loved prescription in a “quit this” headline invites both reader backlash and Meta / claims scrutiny, and there’s no legal sign-off yet.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 90 | Spiro is the dominant recommendation across the VOC and the Rx refugee is actively comparison-shopping a non-prescription route — a large, motivated, self-aware pool. |
| Message–market match (angle) | 88 | The 7 reasons are lifted straight from real reader friction; the double-bind pivot names a gap even the best pill leaves open. Congruent hook→asset→page. |
| Awareness & sophistication fit | 82 | Solution-aware Stage 4–5 reader needs a new mechanism + honest concession, which the listicle delivers; slight risk it reads too soft for the most jaded skimmer. |
| Proof sufficiency | 78 | Capped — real before/afters pending |
| Offer & economics fit | 80 | $49 Acne Core as low-CPA entry + $97 anchored Full System fits a comparison-shopper; 60-day keep-the-gummies reversal de-risks the switch from a “working” pill. |
| Compliance risk | 68 | Naming a beloved Rx in a “quit this” frame carries real brand-safety + claims exposure; copy stays cosmetic and honest, but no legal sign-off yet (hard-capped ≤80). |
| Production feasibility & cost | 85 | Editorial advertorial is cheap to build — copy is written; needs real photography + before/after slots and light design, no video or complex assets. |
| Channel fit | 80 | Long listicle advertorial is native to Meta feed pre-sell; risk is the “quitting a medication” angle tripping ad review — softer creative variants needed as backup. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
An honest scorecard of the 9 things women over 40 actually try — graded straight, so the reader trusts us enough to hear the tenth.
This is the trust-buy for a jaded, comparison-shopping ICP2 who has already tried spironolactone, tretinoin and birth control and is done being sold to. A ranked, honest scorecard earns the right to sell by admitting that some of these things genuinely work — which is exactly why the reader believes us when we say each one still falls short of the over-40 double-bind. The belief we must shift: “every acne solution either works OR is gentle — never both.” It hands the sales page a reader who now sees the double-bind as the real, unnamed problem and Livyond as the only option built for it — not another product to add to the pile of things that stripped, purged, or came with a prescription.
We ranked 9 hormonal-acne fixes women try after 40 — honestly. Spironolactone works… until it doesn’t. Here’s the whole scorecard.
Tried spiro, tretinoin, the “clean” brands, the drugstore kits? Here’s what actually works after 40 — and the one thing built for skin that breaks out AND dries out.
An honest ranking of every hormonal-acne “fix” — no affiliate spin. #9 is a waste of money. #1 is the one nobody talks about for skin over 40.
Editorial masthead look, not a product ad — reader must feel they’re reading a review, not a pitch. No product shown above the fold. A/B test the headline number (“9 Fixes” vs “9 Things Women Try”). Include a subtle “Reviewed & ranked · updated 2025” date stamp for credibility.
Open with the worst option so the honesty reads as ruthless, not promotional. This is a real verbatim quote (1 of up to 4). Keep verdict labels visually consistent across all 9 items (colored chip: Skip / Works, with caveats / Best for the double-bind).
This is the block that lets us later position Livyond as gentle AND effective — plant the “gentle without being useless” gap here. Honesty note: we do NOT claim fragrance-free ourselves (Livyond has citrus EO) — so avoid over-attacking “fragrance” here; attack lack of efficacy instead.
Frame as “expensive maintenance, not a solution” — this reader is cost- and time-fatigued (“I was hoping to avoid another costly visit”). This is a real verbatim quote.
Fair, not dismissive — keeps the scorecard credible AND soft-plants the gummies (support role, no health claims). Compliance: no “treats hormones” language; keep to “support.”
Speaks directly to the anti-Rx spine of ICP2. Give real credit (“works for some”) so the honesty holds. This is a real verbatim quote (this makes 4 total — stop here).
This is the pivot block: it names the mechanism the sales page pays off — gentle, buffered actives beat harsh solo actives after 40. (BP quote paraphrased/short-trimmed, not attributed as a headline quote to stay under the 4-verbatim rule.)
Give tretinoin real respect (it earns the #3 rank) — the honesty is the whole strategy. Emphasize barrier tolerance as the disqualifier, which is the exact gap Livyond fills.
Rank it #2 and mean it — overselling the downside here would break trust with an ICP2 who has friends spiro helped. The strategic point: even the best option ignores the double-bind. (Spiro quote short/paraphrased to respect the 4-verbatim cap.)
This is the fulcrum of the whole listicle — the reveal that reframes 9 “failures” as one unnamed problem. Consider a simple two-column visual: “Works but strips” vs “Gentle but doesn’t work.” No product yet — hold to ~65% scroll.
First product mention lands at ~70–75% scroll, framed as the honest #1 — NOT the loudest. Name the 4 phases (Purifying Cleanser · Vitamin C Serum · Hyaluronic Restoration Cream · Firming Cream) + gummies. Compliance: cosmetic claims only — “the inflamed look,” never treat/cure. Firming Cream = position as optional night step (coconut oil). Note “no synthetic fragrance, patch-test advised.”
Real numbers only. Before/afters are SLOTS to fill from the 5 client-owned images — do not invent specifics. Press logos [confirm]. Keep an implied FDA-style disclaimer visible near any results.
Anchor the $299.86 value against $97. Recommended tier visually flagged. Risk reversal = 60-day money-back, keep the gummies — NEVER “guaranteed results.” CTA button routes to the Double-Bind sales page, not straight to cart (this is a pre-sell).
Soft, congruent hand-off — no hard-sell close. The CTA promise (“calm-not-strip”) must match the sales-page hero word-for-word.
The CTA carries the identical promise forward — “clears without stripping” / “built for the double-bind” — so the sales-page hero feels like the next paragraph, not a new pitch. The reader arrives already believing (a) the double-bind is the real problem, (b) even the best options ignore it, and (c) Livyond is the honest #1. The sales page then goes deep on the 4-phase mechanism, before/afters and the offer ladder to the same ICP2 avatar with zero tonal whiplash.
Primary KPI: CTR from the listicle to the Double-Bind sales page (pre-sell click-through), and downstream page → checkout rate.
Watch: scroll depth to the #1 reveal (~65–70%) — if readers drop before it, the ranking is too long or item copy too heavy. Also bounce on the spiro/tret blocks (over-selling downsides kills trust).
First test: the reveal placement — hold the double-bind name to block 10 (current) vs seed it earlier in the intro. Trust-based listicles usually win by delaying the frame.
The honest-scorecard format is the single best-matched vehicle for a jaded, comparison-shopping ICP2 — the strategy IS the credibility, and message–market match is the strongest dimension here. The biggest lever is proof: the reveal and offer are tight, but the before/afters are still slots and press logos are unconfirmed, which caps the ceiling. The main risk is compliance — a listicle that grades prescriptions (spiro, tretinoin, birth control) and then sells a cosmetic needs legal sign-off on the OTC-vs-Rx framing before it runs on Meta.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 90 | Massive, loud, underserved demand — “tried everything,” “nothing works” is the dominant thread in the VOC; women are actively comparison-shopping fixes. |
| Message–market match (angle) | 88 | Honest ranking is the ideal Stage 4–5 trust-buy; the double-bind reveal reframes 9 failures as one unnamed problem — near-perfect fit for the anti-Rx ICP2. |
| Awareness & sophistication fit | 86 | Solution-aware reader who already knows the players; scorecard meets them at their exact stage without insulting or re-educating them. |
| Proof sufficiency | 72 | Capped — real before/afters pending; 4.9★/847/20,000+ are solid but press logos [confirm] and the 5 journeys are still slots to fill. |
| Offer & economics fit | 82 | $49 low-CPA entry into $97 recommended stack with strong anchor and keep-the-gummies reversal; clean ladder, good AOV path for a pre-sell. |
| Compliance risk | 68 | Capped — no legal sign-off yet; grading prescriptions then selling a cosmetic is the sharpest edge; EO/coconut liabilities and results claims need review. |
| Production feasibility & cost | 85 | Copy-driven editorial page, cheap to build and iterate; main cost is sourcing/shooting the 5 real before/afters and confirming press. |
| Channel fit | 84 | Long-form honest listicle is a proven Meta/Google pre-sell format; congruent hooks feed it well; strong native-editorial fit for cold traffic. |
Copy-paste into your image model. One tall, single-column image of the entire asset.
A cold video pre-sell that names the double-bind out loud, reframes it as a hormone problem no product was built for, and hands warmed traffic to the sales page — before it ever sees a price.
This is the top of the funnel for the coldest traffic — women 40–55 who are problem-aware (they know their skin is a mess) but not solution-aware for a double-bind product. The video’s only job is to reframe: from “I have acne, I need something stronger” to “I have a hormone-driven double-bind, and everything strong is exactly what’s wrecking my skin.” It must earn 2–4 minutes of attention from a Stage 4–5 skeptic who has heard every acne pitch, install a NEW mechanism (calm-not-strip), and pass a pre-sold, belief-shifted viewer to the Double-Bind sales page with the same promise intact.
“If your skin is breaking out AND drying out at the same time — you don’t have acne. You have a hormone problem no acne product was built for. Here’s the 4-minute fix.”
“Clear skin for 20 years — then 42 hit and it went wild like I was a teenager again. What finally worked wasn’t stronger. It was gentler.”
“Every acne product tells you to strip, dry, and peel. For perimenopausal skin, that’s the exact reason it’s getting worse. Watch before you buy another one.”
B-roll: fast, unglamorous first-person mirror shot — a real 40s+ woman touching a sore chin, no filter. No logo, no product yet. Big on-screen text captions the spoken hook for sound-off feed viewing. This is the scroll-stopper; A/B the first 3 seconds against Hook B and Hook C openers.
On-screen text stacks the callout markers (“42… 45… 48…”) so a scrolling viewer self-identifies fast. State the payoff up front — Stage 4–5 viewers won’t wait for a slow build. Keep “clears without stripping” verbatim; it is the through-line to the sales page.
Overlay this verbatim VOC quote as an on-screen testimonial card (r/Perimenopause): “I feel like a teenager again. My skin had been clear for years. I’ve been that woman that everyone compliments all the time. And now, suddenly…. It’s out of control.” Cut to warm, empathetic talking-head. This beat builds identification before any pitch — do not rush it.
Simple animated diagram: estrogen line dropping → two arrows splitting to “more breakouts” and “thinner, drier barrier.” This is the reframe that reclassifies the problem — it must land clearly. Keep it cosmetic and calm; describe “the inflamed look,” never treat/cure. No cancer, no disease language.
Rapid on-screen “strike-through” list: BP · salicylic · tret · spiro · Accutane · “clean” creams — each crossed out as spoken. Stay honest and specific (this is what disarms a jaded Stage 5 viewer). Do NOT overclaim against Rx — acknowledge spiro works for some, then pivot to the non-Rx, gentle route they actually want.
Clean ingredient hero shots — niacinamide as the efficacy hero, soursop as the ownable brand hero (say “antioxidant-rich,” never health claims). Introduce the “calm-not-strip” mechanism as the new category. Product/price still NOT shown — hold the reveal to the next beat. Cosmetic language only.
Show the 4 phases as numbered cards / quick hands-on demo (cleanse → serum → cream). Position Firming Cream honestly as a NIGHT/optional step — it contains coconut oil, so never frame it as the daytime acne step. Add a subtle on-screen note: “no synthetic fragrance · patch-test advised.” First product reveal lands here at ~65% — on target for a Stage 4–5 pre-sell.
Overlay real VOC testimonial cards (r/SkincareAddiction): “I just needed to get the basics right (proper, gentle cleansing, a good moisturiser, and a few bulletproof actives)… sometimes you don’t need powerful actives or trendy products to get real results.” and (r/Perimenopause): “I have reached the point in my life where I cannot try a lot of products or get crazy with my skincare routine. The simpler, the better.” Fill the 5 client-owned before/after slots (don’t invent specifics). Show 4.9★ / 847 reviews / 20,000+ customers on screen. Add press logos only if confirmed [confirm: Marie Claire, Byrdie, NewBeauty].
On-screen offer ladder: Acne Core $49 → Full System $97 (anchor $299.86, mark ★ recommended) → 2 Systems $169. Show the 60-day money-back + “keep the gummies” badge. NEVER say “guaranteed results” — guarantee = money-back only. Imply the FDA-style disclaimer on screen. This beat pre-sells price so the sales page just confirms it.
Single, unmissable CTA button under the video: “See the 4-Minute Routine →” pointing to the Double-Bind sales page. End card holds the promise line + 4.9★ + 60-day badge on screen for 3–5 seconds. One CTA only — don’t split intent. A/B the button copy against “Start My 60-Day Trial →.”
The CTA carries the exact same promise (“clears without stripping,” the 4-minute routine, 60-day money-back) so the sales-page hero reads as a continuation, not a restart. The viewer arrives already pre-sold on the mechanism (calm-not-strip) and the price ($97 Full System), so the page’s job narrows to confirming the offer, showing the full before/after set, and closing on the AOV ladder — not re-teaching the double-bind. Same avatar, same voice, same wedge, warmer temperature.
Primary KPI: Click-through rate from VSL to the Double-Bind sales page (and cost per pre-sold click), plus assisted conversion / ROAS on cold traffic.
Watch: 3-second and 25% / 50% / 75% video retention — especially the drop at the mechanism reveal (beat 04) and the product/price reveal (~65%, beat 07). Also thumb-stop rate on the first 3 seconds.
First test: The 0:00–0:15 pattern-interrupt hook — test the double-bind callout (Hook A) vs. the “gentler, not stronger” story open (Hook B). The opener drives everything downstream; win the hook before touching anything else.
The angle–market fit is the strongest thing here: the double-bind is a real, under-served wound and the “calm-not-strip” reframe is genuinely new for a Stage 4–5 audience, which is exactly what a cold VSL needs. The score is held down by two honest gaps — the real before/afters aren’t in hand yet, and there’s no legal sign-off on the botanical/OTC framing. The single biggest lever is proof: drop 3–5 real, labeled before/afters into beat 08 and this jumps to low-80s. Main risk is production — a 4-minute VSL is the most expensive asset in the funnel to make well, and a weak hook wastes all of it.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 88 | Perimenopausal/hormonal acne in women 40–55 is a large, growing, high-emotion market; VOC shows relentless “tried everything” demand and a clear appetite for a gentle OTC route. |
| Message–market match (angle) | 84 | The double-bind + calm-not-strip reframe maps directly onto the shared wound across all three ICPs; hook, promise and mechanism stay congruent end to end. |
| Awareness & sophistication fit | 80 | New-mechanism + identification is the correct Stage 4–5 play for cold, less-aware traffic; VSL length gives room to reframe before pitching. Slight risk it’s still too long for the coldest Meta feed. |
| Proof sufficiency | 72 | Capped — real before/afters pending. Strong VOC quotes and 4.9★/847/20,000+ help, but before/after slots are unfilled and press logos are unconfirmed. |
| Offer & economics fit | 78 | Clear ladder ($49 / $97★ / $169) with a strong anchor and 60-day/keep-the-gummies reversal; low-CPA Acne Core entry suits cold traffic. VSL production cost pressures front-end ROAS until scaled. |
| Compliance risk | 72 | Script holds cosmetic framing, avoids cancer/disease and “guaranteed results,” and flags coconut oil / no-synthetic-fragrance honestly — but no legal sign-off yet on soursop/botanical claims, so capped. |
| Production feasibility & cost | 62 | Highest-cost asset in the funnel: needs a credible on-camera talent 40–55, real b-roll, animation for the mechanism, and quote/before-after cards. Slow, expensive to iterate vs. static ads. |
| Channel fit | 79 | Strong on YouTube in-stream and Meta feed for a reframe story; captions handle sound-off. 4-minute runtime is ideal for YouTube, on the long side for cold Meta — needs a cut-down. |
Copy-paste into your image model. One tall storyboard image — every VSL beat as a stacked frame.
A diagnostic pre-sell that turns a jaded, “tried-everything” shopper into a segmented, self-identified lead — then hands each of the 3 ICPs a personalised result and the matched SKU.
Cold women 40–55 are problem-aware but Stage 4–5 skeptical — they’ve tried spiro, tret, birth control, “clean” brands, and derms, and a plain product claim bounces off them. The quiz sidesteps the pitch: it makes the reader diagnose herself, which lowers her guard, feels like help not selling, and earns the right to an email. Its one belief-shift job: “your breakouts aren’t random — they have a nameable cause, and there’s a matched fix.” It hands the sales page a warm, segmented lead who arrives already identified as one of three “skin profiles” mapped to a specific offer (Acne Core vs Full System).
“Breaking out at 45 — and drying out at the same time? Take the 2-minute quiz to find out which kind of hormonal skin you actually have.”
“Clear skin for 20 years, then ‘second puberty’ hit. There are 3 types of perimenopausal breakout — and they don’t use the same fix. Which one are you?”
“If acne products leave your skin stinging and flaky, you’re treating the wrong problem. Take the 2-min quiz — get the routine matched to your skin.”
Above the fold, one calm before/after or textured-skin lifestyle image — NOT a product shot (product stays hidden until the result). Big single CTA, progress dots visible so “2 minutes” feels true. A/B test the headline against the Hook-B “3 types” framing.
Opener is easy, non-threatening, and instantly signals “this quiz is for women like me.” Also seeds the perimenopause frame without saying “menopause” in the ad. Low-stakes first click drives completion.
Splits the “blindsided” newcomer (ICP1) from the battle-hardened Rx refugee (ICP2). Mirrors real VOC: “Clear skin for 20 years, then suddenly out of control.” This is the strongest single sorting question — weight it heavily in scoring.
Chin/jawline is the dominant hormonal-acne location in the VOC (“a collection of them on my chin”). Confirming her lived pattern back to her builds credibility — “this quiz actually gets it.” Feeds the result copy, not the ICP branch.
The wedge question — this is where the double-bind gets named. It is the single most resonant cluster in the VOC (“super dry AND getting acne,” “burning my face off with harsh actives”). Any “yes” here should hard-route toward the ICP3 profile regardless of other answers.
The kill-list, asked as self-report so it never feels like we’re bashing her doctor. Multi-select: heavy Rx / “tried everything” selection is the clearest ICP2 tell (“tried literally everything — two rotations on accutane, spiro, antibiotics…”). “Not much yet” reinforces ICP1.
Confirms sensitivity for the ICP3 branch and, crucially, sets up the compliance-safe reassurance on the result screen (patch-test, no synthetic fragrance, citrus-oil / photosensitivity note). Mirrors VOC: “reluctant to try anything harsher.”
The goal question doubles as the SKU router. “Simply and fast” → Acne Core $49 entry; the other three → Full System $97. Mirrors the strong VOC demand for “the simpler the better” on one side and “a complete routine” on the other.
Value exchange, not a gate for its own sake — the reward (personalised result + guide) is named before the ask. Progress dots at ~90% so quitting feels wasteful (commitment/consistency). Single field only. A/B test: gate-before-result (shown) vs show-result-then-email-to-save. Feed email into the flow tagged with the ICP branch for segmented follow-up.
Result screen carries a compliance-safe reassurance line for all profiles: “No synthetic fragrance. Patch-test first, and avoid direct sun right after use (contains citrus oils).” NEVER “fragrance-free,” never disease/cure language, inflammation framed as “the inflamed look.” The three profile headlines are the highest-leverage A/B surface — test them first.
Show the quote that matches the served profile where possible (quote 1 for A/B, quote 2 for C). Real VOC only — no invented reviews. Reserve a before/after slot here (5 real client-owned images exist — fill, don’t fabricate specifics).
Pre-select the matched SKU but let her switch tiers (subscribe & save, 2-Systems $169 visible). Never “guaranteed results” — money-back only. Primary CTA can go straight to a pre-filled cart for warm buyers; secondary routes skeptics (esp. Profile B) to the Double-Bind sales page to finish the sell.
The CTA keeps perfect congruency: the profile headline she just received is the sales-page promise she lands on, and “Clears without stripping” carries through unchanged. Warm buyers (Profiles A & C who clicked the matched SKU) can skip to a pre-filled cart; comparison-shoppers (Profile B) take the “see how it works” secondary link into the Double-Bind sales page with their profile passed as a URL param, so the page opens on the mechanism section that answers their objection. Same avatar, same angle, same offer — no re-selling from scratch.
Primary KPI: Email capture rate (quiz starts → emails) and cost-per-lead from Meta; secondary: quiz-lead → purchase rate vs cold direct-to-page.
Watch: Per-question drop-off (esp. Q4 the double-bind and the Q9 email gate), profile distribution (is one ICP starving?), and matched-SKU CTR by profile.
First test: Email gate placement — gate-before-result vs show-result-then-email-to-save. Then A/B the three profile result headlines.
Demand and angle are the strongest cards here: the double-bind wedge is a real, unmet cluster in the VOC, and the quiz format is ideal for a Stage 4–5 skeptic who won’t accept a plain claim — she diagnoses herself instead. The single biggest lever is the self-segmentation: routing each ICP to a matched SKU should lift both lead quality and quiz-to-purchase. The main risk is production & proof — this needs a real quiz-tool build (logic, branching, email capture) plus the pending before/afters and legal sign-off before it can scale on Meta.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 88 | Perimenopausal / hormonal acne in 40–55 women is a large, loud, underserved market; VOC shows intense “nothing works” demand and OTC-seeking. |
| Message–market match (angle) | 86 | The double-bind (“clears without stripping”) is a genuinely differentiated mechanism for a Stage 4–5 crowd; quiz makes it feel like diagnosis, not a pitch. |
| Awareness & sophistication fit | 84 | Problem-aware Stage 4–5 skeptics resist claims but engage with self-diagnosis; quiz lowers guard before any offer. Slight risk of feeling “gamey” to the most jaded. |
| Proof sufficiency | 78 | Capped — real before/afters pending; result-screen proof leans on VOC quotes + 4.9★/847/20k [confirm] until client images land. |
| Offer & economics fit | 80 | Q7 SKU routing (Acne Core $49 entry vs Full System $97) fits the ladder well; low-CPA entry for cold, upgrade path for solution-seekers. Quiz should raise AOV via matched Full System. |
| Compliance risk | 72 | Capped — no legal sign-off yet. Cosmetic-only framing, money-back not “guaranteed,” citrus-oil / patch-test / photosensitivity notes are built in, but result-screen “cause” language and soursop need review. |
| Production feasibility & cost | 66 | Heaviest lift of any asset here: needs a real quiz engine (branching logic, scoring, email capture, ESP segmentation + pass-through URL params). Not a simple page — build + QA time before launch. |
| Channel fit | 85 | Quiz-to-lead is a proven Meta cold-traffic play and gives clean email segmentation for the follow-up flow; congruent hooks feed it directly. |
Copy-paste into your image model. One tall image — every quiz screen as a stacked mobile frame.
The core conversion page every funnel points to: a POV advertorial that carries the double-bind promise all the way into a buy-on-page offer ladder — “clears without stripping.”
This is the page that has to close the sale. Every ad and every pre-sell asset in the funnel — POV advertorial, listicle, quiz, founder story, retargeting — hands off to here, so the promise on this page must match the promise that got them to click: breaking out AND drying out, cleared without stripping. For cold traffic arriving through a pre-sell, the top of this page re-earns identification in one breath; for warm and retargeted traffic entering direct, the sticky header and above-fold offer let them buy immediately without re-reading the whole story. The belief it must shift for a Stage 4–5 skeptic: “this isn’t another systemic drug or another harsh topical — it’s the first thing built for the exact skin I actually have.” It hands off to checkout with full anchoring already done.
This is the destination, so every pre-sell asset in the funnel feeds this page — the POV advertorial, the “I tried everything” kill-list listicle, the “what’s your peri-skin type” quiz, and the founder story all end their CTA here, carrying the same double-bind promise. The hooks below are the highest-intent, direct-to-page lines for warm and retargeting audiences who’ve already seen a pre-sell and don’t need the full story again — run them straight to the top of this page.
“Breaking out and drying out at the same time? You’re not doing skincare wrong — your skin changed the rules. The gentle 4-phase system for skin that’s cystic AND dry. Clears without stripping. 60-day money-back →”
“No spiro. No Accutane. No 4-month wait. A barrier-safe, pH-5.5 system for hormonal breakouts on grown-up skin — strong enough for the cyst, gentle enough for the dryness. See the system →”
“The full 4-phase system is $97 today (value $299.86) + bonus gummies you keep even if you refund. Still breaking out at 47? Start here →”
Persistent on all viewports. On mobile, collapses to a bottom-fixed ATC bar that appears after the hero scrolls out. Every soft CTA down-page scrolls to this / opens the offer block. A/B: sticky price shown vs price hidden until offer.
Hero before/after image + CTA above the fold. Trust badge row immediately under (block 02). A/B headline: double-bind (shown) vs the second-puberty mirror line “It’s like second puberty — but my skin can’t handle teenager products anymore.”
Thin strip directly beneath hero; repeats as the press wall in block 11 and again above the final CTA. Grayscale press logos once confirmed.
First-person POV open — the moment it started. Keep the “dimmed the lights” and “grown woman crying about a pimple” beats. This is where cold pre-sell traffic re-identifies.
Validate “it’s hormonal’’ (their true belief), then reframe: one root, not two problems. Sets up why one-sided fixes fail. Compliance: “the inflamed look,” never “treats inflammation.”
Problem-of-the-problem: skin → self-esteem → stress loop. Seed the desire (“the woman in the mirror back”) that the offer pays off.
Centerpiece — pre-empts “I’ve tried everything.” Every kill-list entry uses a REAL r/ quote. Table is sticky-scannable on mobile (horizontal cards). This is the belief-shift engine.
The new-mechanism reveal Stage 4–5 needs before you can sell. Efficacy hero = niacinamide (block 08); soursop = ownable brand hero here. Compliance: zero cancer reference, “calm/settle” only.
Product revealed here (~55% scroll) with the honest coconut-oil disclosure baked into Phase 04. First in-body soft CTA — all scroll to sticky ATC. Product-shot carousel of the 4 phases + gummies.
Stage-5 trust block — the EO / photosensitivity / coconut disclosures live here in the open, not buried. NEVER say “fragrance-free.” Confirm every stat before publish.
Placeholder slots only — do not invent specifics. Slider (drag before/after) works best on mobile. Must be filled before launch.
Reddit quotes are real VOC used as social proof of the problem/desire — label the on-site testimonials [REAL REVIEW NEEDED] and swap in attributable customer reviews before launch. Second in-body soft CTA.
Third in-body soft CTA. Compliance: money-back, NEVER “guaranteed results.” Keep-the-gummies is the reciprocity hook.
Anchoring done on-page before the ladder so the $97 lands against $299.86. Itemized box builds the anchor visually.
2-Systems is the decoy that makes $97 feel modest and lifts AOV. Subscribe default-selected. $49 Acne Core catches the price-sensitive skeptic without killing the $97 as the visual hero. Radio-select cards; selecting updates the sticky ATC.
Supply-based scarcity is the only honest kind here — no fake countdown timers. Ties back to the heritage-botanical mechanism.
FAQ carries the EO/photosensitivity + coconut-oil-night-step disclosures a second time. Compliance-safe language throughout.
Final CTA repeats the sticky ATC action. FDA cosmetic disclaimer is mandatory in the footer of this page. Express-checkout options (Shop Pay / PayPal) shown at the ladder and here.
As the destination, this page hands off to checkout, not another page. The sticky ATC and every soft CTA route to the block-14 offer ladder, where the tier the user selects (Acne Core $49 / Full System $97 / 2 Systems $169 / Subscribe) pre-loads into cart with the same promise language carried through — “clears without stripping,” 60-day money-back, keep the gummies. Express checkout (Shop Pay / PayPal) reduces friction for warm buyers. The AOV levers live in the handoff: 2-Systems decoy anchors against $97, Subscribe is default-selected, and a one-click post-purchase upsell (extra gummies / refill subscription) fires on the thank-you page — congruent avatar, no new angle.
Primary KPI: conversion rate + AOV (revenue per visitor). Secondary: cost-per-acquisition blended across the feeding pre-sells.
Watch: scroll depth to product reveal (~55%) and to the offer ladder; add-to-cart → checkout drop-off; which tier wins (guard the $97 as hero vs $49 cannibalization); mobile sticky-ATC tap rate.
First test: above-fold headline — double-bind (control) vs the second-puberty mirror line — since the hero sets identification for all incoming pre-sell traffic. Then test offer default (Full System pre-selected vs Subscribe pre-selected).
This is the strongest possible destination for a Stage 4–5 market: a genuine new mechanism (the double-bind + calm-not-strip), a respectful kill-list that pre-empts “I’ve tried everything,” and a fully-anchored offer ladder that buys on-page. The single biggest lever is the empty before/after wall — five real, consented perimenopausal transformations will do more for conversion than any copy change. The main risk is that the whole page ships without legal sign-off on the ingredient/mechanism claims and the citrus-oil/photosensitivity disclosures. This is the conversion linchpin every funnel points to, so its ceiling is set by proof and compliance, not persuasion.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 92 | Peri/hormonal acne in 40–55 women is a large, painful, underserved market — VOC shows relentless “nothing works” and “second puberty” demand. |
| Message–market match (angle) | 90 | The double-bind (breaking out AND drying out) is a resonant, ownable wedge that carries from ad to page unbroken; “clears without stripping” nails the desire. |
| Awareness & sophistication fit | 88 | Kill-list + new-mechanism + comparison table is exactly the Stage 4–5 playbook; sticky ATC lets warm/retarget buy direct. Slight risk of length fatigue for the most jaded. |
| Proof sufficiency | 72 | Capped — real before/afters pending. Star count, press, experts, founder and VOC quotes are strong, but the 5 hero transformations are placeholder slots and on-site testimonials still need real attribution. |
| Offer & economics fit | 85 | Clean ladder ($49 / $97⭐ / $169 / subscribe) with a real value-stack anchor ($299.86→$97), decoy, and 60-day keep-the-gummies reversal. All figures still [TO-CONFIRM]. |
| Compliance risk | 78 | Copy is disciplined (cosmetic-only, “the inflamed look,” money-back not results, FDA disclaimer, EO/photosensitivity + coconut disclosures) — but no legal sign-off yet, so ceiling held. |
| Production feasibility & cost | 80 | Single long-form page on existing Shopify/theme is buildable now; the gating cost is shooting/sourcing 5 consented before/afters and confirming press logos. |
| Channel fit | 86 | As the universal destination it fits every channel; the sticky ATC + direct-entry hero make it work for both cold-through-presell and warm/retarget paid traffic. |
Copy-paste into your image model. One tall, single-column image of the entire sales page.
A leaner sales-page variant for reactive, barrier-wrecked skin (ICP3) — every block angled on one promise: it clears the breakout without stripping, stinging, or wrecking the barrier you’ve got left.
This is the landing page we send warm, retargeted ICP3 traffic to — women whose skin is breaking out and stinging, flaking, and red, who’ve been burned (literally) by harsh acne products and now brace for pain from anything new. It is the main Double-Bind sales page rebuilt tighter and re-angled entirely on gentleness + barrier safety: the hero, the mechanism, and the proof all foreground “won’t strip, won’t sting, won’t wreck your barrier while it clears.” It must shift one belief — “anything strong enough to clear me will destroy my already-fragile skin” — and it does that by handling the coconut-oil and citrus-EO honesty proactively (patch-test, night-step guidance, no synthetic fragrance) so the skeptic trusts us before she buys. Same offer as the main page; it hands a pre-qualified, low-fear reactive-skin buyer straight into checkout.
If every acne product burns your face and every “gentle” one breaks you out, you’re not doing it wrong. Your peri skin needs something that clears without stripping. Barrier-first, pH-5.5, no sting.
“I braced for the sting. There was no sting.” The 4-phase system for skin that’s breaking out AND flaking, stinging, red — strong enough for the cyst, gentle enough for a barrier that’s already shot.
Reactive skin? Read this first. We’ll tell you straight: no synthetic fragrance, patch-test the citrus, and the richest cream is a night step. Then we’ll show you why it doesn’t strip.
Hero image = a real reactive-skin before/after (redness/flaking case, NOT a glam shot). Caption: “Real Livyond customer, 46, perimenopausal & reactive. Left: a bad, red, flaking week. Right: 8 weeks — no stripping, no sting. Individual experience; results vary.” [REAL REACTIVE-SKIN B/A NEEDED]. Trust badge row: 4.9/5 · 847+ reviews · No synthetic fragrance · Barrier-safe pH 5.5 · Patch-test friendly · 60-day money-back. Sticky ATC appears on scroll. A/B test Headline vs Hook-B testimonial as headline.
Keep this block short and mirror-close — ICP3 bounces if the page reads generic. Two REAL VOC quotes (r/Perimenopause, r/Menopause) verbatim. No product mention yet; earn identification first.
This is the leaner page’s single mechanism block — do NOT expand into the full 4-pillar essay from the main page. Compliance: “calms,” “settles,” “the inflamed look” only. Simple diagram: barrier + pH + hydration knocked out of balance → sting/flake/flare.
The coconut-oil disclosure IS the trust lever for ICP3 — do not soften or bury it. Same for the citrus-EO note on 01/03/04 and the EO-free flag on 02. Sticky ATC + soft CTA button: “See the barrier-safe system →”. Optional short ingredient-transparency strip (niacinamide / glycolic / zinc / 3-GA vit C / dual-weight HA + squalane) below.
Every testimonial here must make the SAME point: it didn’t sting / didn’t strip / put moisture back. Replace the two named quotes with real, attributable reviews saying that. The r/Menopause line is a genuine VOC quote used as framing, not as a customer testimonial — keep the source tag. 4.9/5 · 847+ · 97% would recommend badge row repeats here.
For ICP3, lead the ladder emphasis on Acne Core $49 as the low-fear entry (only the two barrier-safe steps), then upsell to Full System. This differs from the main page, which leads Full System. Sticky ATC. Default-select Subscribe & Save. A/B test Acne-Core-first vs Full-System-first framing.
Never “guaranteed results.” Pair the guarantee with the patch-test line here specifically — for ICP3, “try it safely” is a bigger unlock than “try it free.” Soft CTA: “Try it for 60 days, risk-free →”.
The fragrance + coconut-oil + photosensitivity answers are the point of this variant — handled proactively, they convert the skeptic instead of surprising her post-purchase. Never claim “fragrance-free.”
Two CTAs — Acne Core (low-fear entry) first, Full System second — matching the ICP3 ladder emphasis. FDA cosmetic disclaimer required. Sticky ATC persists.
This variant is the destination — the CTA hands straight into checkout, not into another page. Congruency is the whole game: the “clears without stripping / no sting / barrier-safe” promise from the retargeting ad is the hero, the mechanism, and the CTA button copy, so a reactive-skin skeptic never feels the ground shift under her. If she needs the deeper build (full kill-list, 5 before/afters, expert wall), a “read the full story” link can route her to the main Double-Bind sales page — same avatar, same promise, more proof.
Primary KPI: Purchase conversion rate on retargeted ICP3 traffic (and cost-per-purchase vs the main page for the same audience).
Watch: Scroll depth to the coconut-oil / fragrance FAQ (block 08) — and add-to-cart split between Acne Core $49 vs Full System $97 (does the low-fear entry lift starts?). Also refund rate: proactive honesty should lower it.
First test: Ladder emphasis — Acne Core $49 led first (this variant) vs Full System $97 led first (main page), for reactive-skin traffic. One variable, measured on CVR × AOV.
Strong GO on merit — the angle is tightly matched to a real, painful, underserved segment (reactive double-bind) and the retargeting context means the audience is already warm and self-selected, so message-market match is doing most of the work. The single biggest lever is the coconut-oil / citrus-EO honesty being surfaced proactively: it’s the exact objection this skeptic carries, and handling it up front is what converts her. The main risk is unfixable on paper — real reactive-skin before/afters aren’t dropped in yet and there’s no legal sign-off, so both proof and compliance are capped until pre-launch assets land.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 82 | Reactive-double-bind pain is loud and recurrent in the VOC (“reluctant to try anything harsher,” “my FACE HURTS”); narrower than the main page but that’s the point of a retargeting variant — a warm, self-qualified slice, not cold reach. |
| Message–market match (angle) | 88 | The single tightest dimension: “clears without stripping / no sting / barrier-safe” runs ad → hero → mechanism → CTA with no drift. This is the exact belief ICP3 needs shifted. |
| Awareness & sophistication fit | 80 | Warm/retargeting + Stage 4–5: the calm-not-strip mechanism gives the jaded skeptic a new vehicle, and proactive honesty reads as credibility rather than hype. Slightly leaner mechanism than main page suits a returning visitor. |
| Proof sufficiency | 78 | Capped — real before/afters pending. Reactive-skin testimonials and VOC framing are strong, but the two named reviews and the paired before/after frames are placeholders until consented assets drop. |
| Offer & economics fit | 80 | Acne Core $49 as the low-fear entry is the right ladder for a fear-driven segment (only the two barrier-safe steps, no coconut cream); Full System $97 + Subscribe upsell preserves AOV. Figures still [TO-CONFIRM]. |
| Compliance risk | 80 | Capped — cosmetic-only framing, “calms/settles/inflamed look,” money-back (not guaranteed results), FDA disclaimer, no cancer/soursop overreach, EO + photosensitivity disclosed. Solid, but no legal sign-off yet and prices/press logos unconfirmed. |
| Production feasibility & cost | 84 | It’s a leaner re-cut of an existing page — same offer, fewer blocks. Only net-new production is 2–3 reactive-skin before/afters and a couple of real gentleness reviews; no new mechanism or offer to build. |
| Channel fit | 83 | Meta retargeting is ideal: warm audience, so the page can open on identification and mechanism instead of re-educating. Sticky ATC + short scroll suits returning mobile traffic. |
Copy-paste into your image model. One tall, single-column image of the entire landing page.
An honest head-to-head for the woman who’s already Googling “spironolactone vs retinoids for hormonal acne” — it earns the click by telling the truth, then shows where a calm-not-strip system actually fits.
This is a bottom-funnel destination for the highest-intent searcher we have: she has already tried or researched the prescription route and is actively comparing options. She does not need to be convinced acne is a problem, and she is deeply skeptical of hype — so the page wins by being scrupulously honest. It concedes that spironolactone and retinoids genuinely work for many people, then reframes the real decision around the one dimension no drug is built for: the double-bind of breaking out and drying/stinging at once. The belief it must shift is not “Livyond is better than medicine” — it’s “there is a legitimate, gentle, non-prescription lane, and I fit it.” It hands a pre-qualified, trust-warmed buyer to the Double-Bind sales page or straight to the Acne Core offer.
Spironolactone vs retinoids for hormonal acne? Here’s the honest comparison — plus the non-prescription option nobody puts in the table.
Tried spiro. Tried tret. Skin still breaking out and stinging? You may be solving the wrong problem. See the side-by-side.
Before you ask your derm for Accutane — read the honest head-to-head. No prescription, no strip, no hype.
No product shot up top — lead with a clean split-3 header graphic (Rx bottle / retinoid tube / Livyond system) to signal “fair fight.” Anchor CTA is soft: “Jump to the comparison ↓”, not “Buy.” A/B test the honesty admission (“we won’t trash the prescriptions”) vs a neutral opener.
One line, sets the honest frame and pre-empts the “this is just an ad” reflex. Include a small “Reviewed for accuracy” note only if a real reviewer exists [confirm]. Keep cosmetic-claim-safe: no “treats,” no “cures.”
| Dimension | Spironolactone (Rx) | Retinoids / Tretinoin (Rx) | Livyond (calm-not-strip system) |
|---|---|---|---|
| How it works | Oral pill; blocks androgen activity so skin makes less oil. | Topical Rx; speeds cell turnover to keep pores clear. | 4-phase topical routine; supports the barrier while niacinamide helps the look of oil, pores & inflammation. |
| Prescription needed | Yes — doctor visit, ongoing scripts. | Yes — doctor / telehealth. | No — over-the-counter, no appointment. |
| Common side effects | Can include dizziness, low blood pressure, palpitations, potassium monitoring (varies by person). | Purging, dryness, peeling, redness, sun sensitivity, esp. early on. | Cosmetic routine; patch-test advised. Contains citrus essential oils — avoid direct sun after use. |
| Made for the dryness / barrier double-bind | Not really — targets oil, not barrier or dryness. | Often makes dryness & stinging worse before better. | Yes — this is the whole point. Built to clear without stripping. |
| Time to results | Often weeks to a few months. | Weeks — usually a purge phase first. | A gradual routine; consistency over weeks. |
| Pregnancy / trying to conceive | Generally not advised — ask your doctor. | Generally not advised — ask your doctor. | Topical cosmetic routine — patch-test & consult your doctor if pregnant. |
| Dependency / rebound | Acne often returns if you stop. | Benefits typically fade if you stop. | A routine, not a drug — no prescription to be tied to. |
| Cost | Rx + recurring doctor visits & monitoring. | Rx + visits; prices vary widely. | Acne Core from $49; Full System $97 (value stack $299.86). |
This is THE block — everything above pulls the eye here. Make it horizontally scrollable on mobile with the “Dimension” column frozen. Highlight only the “double-bind” row for Livyond — that’s the earned differentiator; do NOT green-check Livyond across the whole table (that reads as biased and kills trust). Add a small footnote: “Side effects vary by individual. This is general information, not medical advice — talk to your doctor.” Imply the standard cosmetic/FDA-style disclaimer at page foot.
Radical honesty is the conversion lever for this jaded ICP. Genuinely send the wrong-fit person to the drug — it makes the Livyond recommendation credible for the right-fit person. Three equal-weight cards; do not visually inflate the Livyond card.
This is the “new mechanism + identification” Stage 4–5 markets require. Keep it cosmetic: “the look of” oil/pores/inflammation, “calms/settles the inflamed look” — never “treats.” Optional honesty callout box: “Two notes we won’t hide: our Firming Cream contains coconut oil — use it as a night/optional step, not for acne-prone daytime. And our products use citrus essential oils, so patch-test and avoid direct sun after — no synthetic fragrance, but not fragrance-free.”
These are real verbatim Reddit VOC — they legitimize the “there’s a gentle, non-Rx lane” thesis in customers’ own words without Livyond claiming anything. Pair with 4.9★ · 847 reviews · 20,000+ customers and the 5 real acne before/after slots (fill with client-owned images, don’t invent specifics). Press: Marie Claire, Byrdie, NewBeauty [confirm logos].
Anchor the $97 with the $299.86 value stack (PSY-ANCHOR) and set it as the visual default. Because this reader is price-comparing against recurring Rx + doctor-visit costs, contrast one-time OTC vs ongoing prescription cost right here (PSY-CONTRAST). CTA: “Start with Acne Core — $49.”
60-day money-back + keep-the-gummies directly answers this ICP’s fear of another wasted spend and another commitment. Never phrase as “guaranteed results” — money-back only. Note the “nothing to cancel” angle: it’s the anti-dependency payoff of the whole page.
Restate the honest concession one last time so the close never over-claims. Sticky mobile CTA bar throughout. Two exits: high-intent → straight to Acne Core; still-deciding → the Double-Bind sales page. A/B test single-CTA vs dual-CTA.
The primary CTA hands off to the Double-Bind sales page with the exact same promise — “clears without stripping” — and the same avatar (the Rx-tired, reactive-skinned perimenopausal woman). Because this page has already conceded the drugs’ strengths and named the double-bind, the sales page can skip re-earning trust and go deeper on mechanism, before/afters and the offer. High-intent clickers who chose “Start with Acne Core” skip the sales page and land on checkout with the $49 SKU pre-selected.
Primary KPI: Click-through to sales page / Acne Core, then assisted conversion rate. Secondary: revenue per visitor (this page absorbs the most expensive, highest-intent clicks).
Watch: Scroll depth to the comparison table and time-on-table; comparison-term keyword quality score & CPC; bounce from searchers who came only for drug info (expected — the honest fork is doing its job).
First test: The table’s honesty calibration — single highlighted “double-bind” row for Livyond vs a fuller comparison. Hypothesis: the restrained, one-row version out-converts because it reads as fair, not sales-y.
This page targets the sharpest-intent, hardest-to-convert searcher we have, and the radical-honesty comparison angle is exactly right for a Stage 4–5 comparison-shopper — that’s what carries the score. The single biggest lever is proof: real before/afters from women who left the Rx route would move this from “credible argument” to “proven alternative.” The main risk is brand-safety — naming and comparing against prescription drugs without legal sign-off is the one thing that could sink it.
| Dimension | Score | Why |
|---|---|---|
| Demand / market fit | 72 | Bottom-funnel = smaller volume, but comparison searchers (“spiro vs retinoids”) are high-intent and under-served; scored for value-per-visitor, not raw volume. |
| Message–market match (angle) | 88 | The honest head-to-head + “non-Rx lane” maps precisely onto ICP2’s active question; the double-bind is the differentiator no drug owns. |
| Awareness & sophistication fit | 85 | Most-aware, jaded Stage 4–5 buyer; conceding the drugs’ strengths is the only credible open — the page does that. |
| Proof sufficiency | 70 | Capped — real before/afters pending. Real VOC quotes carry it for now, but the alternative-to-medicine claim needs owned visual proof. |
| Offer & economics fit | 80 | $49 low-CPA entry + one-time-vs-recurring-Rx-cost contrast is a strong fit for a price-comparing refugee; 60-day + keep-gummies de-risks the switch. |
| Compliance risk | 62 | Capped — no legal sign-off yet. Comparing against named prescription meds raises brand-safety and claim risk; copy stays cosmetic and honest, but needs review before launch. |
| Production feasibility & cost | 84 | One long-scroll page, one table, existing copy/quotes; only real dependency is client-owned before/after assets and a legal pass. |
| Channel fit | 82 | Google comparison/non-brand terms + retargeting are the natural home for a head-to-head; intent and format align tightly. |
Copy-paste into your image model. One tall, single-column image of the entire comparison page.